US20080255601A1 - Apparatus and method for remote deflation of intragastric balloon - Google Patents
Apparatus and method for remote deflation of intragastric balloon Download PDFInfo
- Publication number
- US20080255601A1 US20080255601A1 US11/735,194 US73519407A US2008255601A1 US 20080255601 A1 US20080255601 A1 US 20080255601A1 US 73519407 A US73519407 A US 73519407A US 2008255601 A1 US2008255601 A1 US 2008255601A1
- Authority
- US
- United States
- Prior art keywords
- balloon
- valve
- intragastric balloon
- shape memory
- deflation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/003—Implantable devices or invasive measures inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0036—Intragastrical devices
- A61F5/004—Intragastrical devices remotely adjustable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
Definitions
- the present invention is directed to devices and methods that enable remote deflation of intragastric balloons used for the treatment of obesity, and in particular devices and methods that enable an implanted intragastric balloon to be remotely deflated while the device itself is in the stomach.
- Intragastric balloons are well known in the art as a means for treating obesity.
- One such inflatable intragastric balloon is described in U.S. Pat. No. 5,084,061 and is commercially available as the BioEnterics Intragastric Balloon System (sold under the trademark BIB®). These devices are designed to provide therapy for moderately obese individuals who need to shed pounds in preparation for surgery, or as part of a dietary or behavioral modification program.
- the BIB System for example, consists of a silicone elastomer intragastric balloon that is inserted into the stomach and filled with fluid.
- Commercially available intragastric balloons are filled with saline solution or air.
- the intragastric balloon functions by filling the stomach and enhancing appetite control.
- Placement of the intragastric balloon is non-surgical, usually requiring no more than 20-30 minutes. The procedure is performed gastroscopically in an outpatient setting, typically using local anesthesia and sedation. Placement is temporary, and intragastric balloons are typically removed after six months.
- intragastric balloons utilized for this purpose are placed in the stomach in an empty or deflated state and thereafter filled (fully or partially) with a suitable fluid.
- the balloon occupies space in the stomach, thereby leaving less room available for food and creating a feeling of satiety for the patient.
- Clinical results with these devices show that for many obese patients, the intragastric balloons significantly help to control appetite and accomplish weight loss.
- Intragastric balloons typically are implanted for a finite period of time, usually lasting approximately six months. This time period may be shortened by a treating physician who wishes to alter the patient's treatment and remove the balloon prior to the six month period. In any event, at some point after the balloon has been surgically placed in the stomach, it will become desirable to remove the balloon from the stomach.
- One of the means of removing the balloon is to deflate it by puncturing the balloon, and either aspirating the contents of the balloon or allowing the fluid to pass into the patient's stomach. This means of removing saline from the balloon requires surgical intervention, through the use of a gastroscopic instrument. When the balloon is deflated in this manner, the balloon itself may be surgically removed using the gastroscopic instrument.
- the acids present in a patient's stomach may erode the balloon to the point where it self-deflates.
- the deflated balloon may pass naturally through the patient's digestive system and be expelled through the bowel.
- the present invention is directed at overcoming the problems associated with the prior art systems.
- the present invention addresses the above-described problems by providing apparatuses and methods for the remote deflation of an intragastric balloon.
- the present invention allows a physician to remotely deflate an intragastric balloon from outside the body, utilizing a remote control that triggers the deflation with an activation signal.
- the apparatus of the present invention includes a meltable wax plug that melts to cause the opening of a valve.
- the microelectronics contained in the valve assembly Upon receipt of an activation signal sent by the physician from a remote control outside the body, the microelectronics contained in the valve assembly cause the temperature of heating element(s) contained within the valve to melt the wax plug. Once the wax plug has melted, thus causing the balloon valve to open, the normal movements of the stomach cause the fluid contained within the balloon to empty from the balloon, causing deflation. The patient is able to then pass the balloon.
- the apparatus of the present invention includes a remote deflation valve having a shape memory element spring that holds a plug in place, thus sealing the valve of the intragastric balloon.
- the shape memory element spring may be heated remotely by induction, or the deflation mechanism may include microelectronics to cause heating of the spring.
- the deflation mechanism may include microelectronics to cause heating of the spring.
- the spring changes shape as a result of the application of heat, it removes the plug, thus causing the balloon to unseal.
- the fluid contained in the balloon may then flow freely out of the balloon, thus causing the balloon to deflate.
- the patient is then able to safely pass the deflated balloon.
- the intragastric balloon includes a remote deflation mechanism with a shape memory element actuator, a spring collar, an obstruction that holds the spring collar in place and a slit valve.
- the shape memory element actuator may be heated remotely by induction or may alternatively include microelectronics and heating elements contained within the deflation mechanism.
- the deflation mechanism When the deflation mechanism is activated, the actuator pushes the obstruction out of the valve, thus allowing the spring collar to contract. The contraction of the spring collar causes the slit valve to open, which allows fluid contained in the balloon to flow out of the balloon and drain accordingly. The patient is then able to pass the deflated balloon.
- a shape memory element “cutting wire” is employed in the remote deflation mechanism.
- the wire when heat is applied to the shape memory alloy wire contained within a remote deflation valve, the wire changes shape, causing the wire to cut through a wax (or other suitable material, e.g. plastic or polymer) plug that seals the valve. Once the wax plug has been cut from the valve, fluid is able to freely flow through the valve, thus allowing the balloon to drain and pass from the body.
- the remote deflation mechanism of the intragastric balloon includes a wire that surrounds the valve.
- the wire is used to break the bond between the valve and the balloon. When the bond between balloon and the valve is broken, the valve separates from the balloon, and fluid flows freely from the balloon.
- This preferred embodiment has the added benefit that the balloon and valve assembly may pass through the body separately, thus allowing passage to occur more easily, as the device is in two separate pieces.
- the valve could be contained in a cylindrical capsule (taking the shape of a large pill, for example) that fits within a collared opening of the balloon shell to create a seal.
- the collared opening could include a spring or other such mechanism that would retain the size and shape of the collar.
- the remote deflation mechanism When the remote deflation mechanism is activated, the spring is released, thereby opening the collar and ejecting the cylindrical capsule from the balloon, rendering two separate components that could then easily pass through the gastrointestinal track.
- the collared opening could include a heating element, which when the remote deflation mechanism is activated, would cause the seal between the capsule and the collar to break, thereby ejecting the cylindrical capsule from the balloon.
- the cylindrical capsule could contain a mechanism such as a spring (a torsional spring, for example), that retains the shape and size of the capsule, holding the capsule in place within the collared opening of the balloon shell.
- a spring a torsional spring, for example
- FIG. 1 is an elevated side view of an intragastric balloon of the present invention.
- FIG. 2 a is a side cut-away view of a remote deflation valve according to one embodiment of the present invention, which shows the valve in the “closed” position.
- FIG. 2 b is a side cut-away view of the remote deflation valve of FIG. 2 a shown in the “open” position.
- FIG. 3 a is a side cut-away view of a remote deflation valve according to a further embodiment of the present invention, which shows the valve in the “closed” position.
- FIG. 3 b is a side cut-away view of the remote deflation valve of FIG. 3 a shown in the “open” position.
- FIG. 4 a is a side view of a remote deflation valve according to yet a further embodiment of the present invention, which shows the valve in the “closed” position.
- FIG. 4 b is a side cut-away view of the remote deflation valve of FIG. 4 a shown in the “open” position.
- FIG. 5 a is a side view of the remote deflation valve of FIG. 4 a which shows the valve in the “closed” position.
- FIG. 5 b is a side view of the remote deflation valve of FIG. 4 b shown in the “open” position.
- FIG. 6 a is a side cut-away view of a remote deflation valve according to still a further embodiment of the present invention, which shows the valve in the “closed” position.
- FIG. 6 b is a side cut-away view of the remote deflation valve of FIG. 6 a shown in the “open” position.
- FIGS. 7 a and 7 b show a top view of an embodiment of the wire cutting mechanism of the remote deflation valve of FIGS. 6 a and 6 b.
- FIGS. 7 c and 7 d show a further embodiment of the wire cutting mechanism of the remote deflation valve of FIGS. 6 a and 6 b.
- FIG. 8 a shows an elevated side view of an intragastric balloon of the present invention with a deflation mechanism surrounding the valve prior to the deflation mechanism being activated.
- FIG. 8 b shows an elevated side view of FIG. 8 a after the deflation mechanism has been activated.
- FIG. 9 is a front view of a remote control for activating a remote deflation valve according to the present invention.
- FIG. 10 a is a side cut-away view of a remote-deflating intragastric balloon according to still a further embodiment of the present invention, which shows the balloon in the “closed” position.
- FIG. 10 b is a side cut-away view of the remote-deflating intragastric balloon of FIG. 10 a shown in the “open” position.
- FIG. 11 is a side cut-away view of a remote-deflating intragastric balloon according to still a further embodiment of the present invention, which shows the balloon in the “closed” position.
- the present invention is directed to a method and device for remotely deflating an intragastric balloon without requiring surgical intervention.
- the intragastric balloon 10 includes a shell 12 , fill valve 14 , and remote deflation valve 16 .
- an un-inflated balloon 10 may be positioned in the stomach in a desired location. Once the balloon is positioned, it may be inflated using fill valve 14 , and those experienced in the art will appreciate that there are several different methods for inflating the balloon, such as disclosed in commonly assigned International Application Number PCT U.S. 03/19414, entitled “Two Way Slit Valve”, the disclosure of which is incorporated in its entirety herein by reference.
- the balloon After implantation, it may become desirable to remove the balloon. In order to remove the balloon it must first be deflated. Once deflated, the balloon may be allowed to naturally pass through the body upon deflation, or alternatively the balloon may be surgically removed using a minimally invasive gastroscopic procedure.
- the present invention is designed such that the deflated intragastric balloon and integrated remote deflation valve may naturally pass through the human body.
- Remote deflation valve 16 is comprised of sealing plug 30 , heating element(s) 31 , microelectronic control 32 and power source 33 .
- the power source 33 may be a battery, capacitor, induction coil, kinetic energy creation by body motion stored onto a capacitor, fuel cell, power source powered by chemistry of the body, or a power source powered by temperature change.
- the sealing plug 30 is preferably formed of suitable medical-grade wax, such as paraffin, or may also be a lower temperature melt polymer. Any type of suitable medical-grade wax, such as paraffin, may be used for sealing plug 30 .
- the patient may be brought into the physician's office in an outpatient setting.
- the physician activates the valve opening mechanism remotely and from outside the body, using a remote control 100 such as that depicted in FIG. 9 .
- the physician holds remote control 100 near the stomach of the patient, and upon depression of button 101 , remote control 100 sends an activation signal, which my be comprised of radio waves, sonic waves, or any other waves suitable for transmitting a small activation signal through the tissue of the abdominal cavity to the implanted balloon.
- Microelectronic control 32 has an antenna (not shown) for receiving the activation signal from remote control 100 . Upon receiving the activation signal, microelectronic control uses power from power source 33 to begin increasing the temperature of the heating element(s) 31 .
- a metal film heating element utilizing metals (such as nichrome, stainless steel, copper, gold, etc.) can be used for heating element(s) 31 .
- the sealing plug 30 begins to melt. Ideally, the melting point of the sealing plug will be slightly above the temperatures in the stomach to ensure that the valve stays closed in its normal operating environment.
- wicking surfaces 34 which may be composed of a contoured reservoir. Ideally the wax will melt and be expelled into the stomach for rapid quench cooling and passage through the intestines. The collection of the wax or other sealing material on wicking surfaces 34 prevents it from clogging capillaries 35 and allows the fluid contained within intragastric balloon 10 to flow out of the balloon. Once the sealing plug is completely melted and been expelled into the stomach and/or collected on wicking surfaces 34 , capillaries 35 allow the free flow of the fluid contained inside the balloon through valve opening 36 ( FIG. 2 b ).
- the balloon will drain of the fluid contained inside and shrink down to a size that is passable through the body.
- the microelectronics, heating element, and power source are safely contained within the valve structure such that they do not present any danger to the patient.
- the microelectronic control 32 may communicate with the remote control 100 to confirm that the deflation mechanism has been activated. Following receipt of a confirmation signal, the physician and patient may then track the progress of the passing of the device.
- Remote deflation valve 26 is comprised of a shape memory spring 41 , plug 42 , and capillaries 43 . While NiTiNOL is the preferred material for the spring utilized in the present invention, any number of shape memory alloys or polymers, or spring materials, including steels (such as stainless steel, chromium, titanium, etc.), may be used.
- the patient may be brought into the physician's office in an outpatient setting.
- the physician activates the deflation mechanism from outside the body, using a remote control (not shown).
- the spring may be heated remotely by induction from the remote control, or may alternatively include microelectronics for receiving an activation signal and controlling heating elements similar to those described in the previous embodiment.
- FIG. 3 b shows the valve mechanism in its open position. Because of pressure normally exerted on the balloon by the stomach, the fluid contained therein will flow freely through the capillaries and open channel and into the stomach, thus causing the balloon to deflate. The deflated intragastric balloon is then allowed to pass out of the body.
- the spring may be detachably fixed to a plug comprised of wax or some other similar biodegradable material. In this way, when the spring is heated and changes shape, it may be used to eject the biodegradable plug into the stomach, thus allowing the balloon to drain. The deflated intragastric balloon would then be allowed to pass out of the body.
- FIGS. 4 a , 4 b , 5 a , and 5 b another preferred embodiment of a remote deflation valve of the present invention is shown.
- FIGS. 4 a and 4 b show a cutaway side view of remote deflation valve 56
- FIGS. 5 a and 5 b show the same valve in a side view.
- Remote deflation valve 56 is comprised of a shape memory actuator 61 , obstruction 62 , slit valve 63 and spring collar 64 .
- NiTiNOL is the preferred material for the actuator of the present invention, any number of shape memory alloys or polymers may be used.
- the physician activates the valve opening mechanism remotely and from outside the body, using remote control 100 .
- the actuator 61 may be heated remotely by induction or alternatively the remote deflation valve may include microelectronics and heating elements.
- the actuator 61 when activated, pushes obstruction 62 out of the valve opening.
- obstruction 62 serves to prevent the slit valve 63 from opening by causing spring collar 64 to be held in its open position, as shown in FIGS. 4 a and 5 a .
- spring collar 64 which is located below the slit valve 63 , contracts. The contraction of spring collar 64 causes the slit valve 63 to be opened, as shown in FIG. 4 b and 5 b . With the slit valve 63 now open, the fluid contained in the balloon may flow through channel 65 and out through the slit valve opening 66 .
- the intragastric balloon is under pressure, and due to the normal movements of the stomach, the fluid contained therein will flow freely through open slit valve 63 and into the stomach, thus causing the balloon to deflate. The deflated intragastric balloon is then allowed to pass out of the body.
- Remote deflation valve 76 is comprised of a shape memory alloy cutting wire mechanism 81 , sealing plug 82 , and capillary 83 .
- NiTiNOL is used in this preferred embodiment, however, any number of suitable shape memory alloys may be used.
- the physician activates the valve opening mechanism remotely and from outside the body, using remote control 100 ( FIG. 9 ).
- the remote deflation valve 76 includes microelectronics (not shown), a battery or other power source (not shown) and heating element(s) 85 ( FIGS. 7 a - 7 d ) for heating the shape memory alloy cutting wire 84 ( FIGS. 7 a - 7 d ).
- the shape memory alloy cutting wire may be heated by induction.
- FIGS. 7 a , 7 b , 7 c , and 7 d show top views of the cutting wire mechanism 84 .
- the shape memory element begins to change shape.
- FIG. 7 a shows the shape memory element cutting wire 84 prior to the application of heat.
- the shape memory element cutting wire 84 Prior to the application of heat, the shape memory element cutting wire 84 is in a curved L-shape, with the curved portion resting around the outside of wax plug 82 .
- the cutting wire may also be in a loop shape that completely encircles the wax plug, as is shown in FIG. 7 c.
- the shape memory element cutting wire mechanism 81 is activated by a signal received from remote control 100 ( FIG. 9 ). Upon receiving the activation signal, the microelectronic control (not shown) uses power from the power source (not shown) to begin increasing the temperature of heating element(s) 85 . As the shape memory element cutting wire 84 begins to change shape as a result of the application of heat, it slices through the sealing plug 82 .
- FIGS. 7 b and 7 d show the shape memory alloy cutting wire 84 in its post-heat application deformed shape, having cut through the sealing plug 82 .
- FIG. 7 a shows a shape memory alloy cutting wire in an L-shaped configuration
- FIG. 7 c shows a shape memory alloy cutting wire in a loop shaped configuration.
- the capillary 83 ( FIG. 6 b ) is now open to allow fluid contained within the intragastric balloon to escape the balloon. Again, because the intragastric balloon is under pressure and due to the normal movements of the stomach, the fluid contained in the balloon will flow freely through the capillary and into the stomach, thus causing the balloon to deflate. The deflated intragastric balloon is then allowed to pass out of the body.
- Intragastric balloon 90 is comprised of shell 97 , valve 91 , valve/balloon bond 92 , heating elements 93 , cutting wire 94 , microelectronic control 95 , and power source 96 .
- FIGS. 8 a and 8 b utilizes a deflation mechanism for separating the entire valve from the remaining portion of the balloon.
- the patient may be brought into the physician's office in an outpatient setting.
- the physician activates the valve opening mechanism remotely and from outside the body, using a remote control 100 ( FIG. 9 ).
- the physician holds remote control 100 near the stomach of the patient, and upon depression of a button, remote control 100 sends an activation signal to the microelectronic control 95 .
- Microelectronic control 95 has an antenna (not shown) for receiving the activation signal from remote control 100 .
- microelectronic control uses power from power source 96 to begin increasing the temperature of heating element(s) 93 .
- metal film heating elements utilizing materials such as nichrome, stainless steel, copper, gold, or other such materials, can be used for heating element(s) 93 .
- the temperature of cutting wire 94 also begins to increase. The increased temperature of the cutting wire causes the valve/balloon bond 92 to deteriorate, resulting in separation of the valve 91 from shell 97 .
- valve/balloon bond 92 Once the valve/balloon bond 92 is broken and the valve is separated from the shell, fluid contained inside the balloon freely flows through the opening 98 that is created by the separation of the two portions. Through the normal movements and contraction of the stomach walls, the balloon will drain of the fluid contained inside and shrink down to a size that is passable through the human body. The microelectronics, heating element(s) and power source are safely contained within the valve structure such that they do not present any danger to the patient. Because the entire intragastric balloon may now be in two separate pieces—an empty shell and a self-contained valve assembly—the passing of the balloon and valve is facilitated.
- the microelectronic control 95 may communicate with the remote control 100 to confirm that the deflation mechanism has been activated. Following receipt of a confirmation signal, the physician and patient may then track the progress of the passing of the device.
- FIGS. 10 a and 10 b another preferred embodiment of an intragastric balloon of the present invention incorporating a remote deflation mechanism is shown.
- Intragastric balloon 109 is comprised of shell 110 and valve capsule 111 .
- Valve capsule 111 is comprised of valve 112 , shape memory torsional spring 113 , and combined microelectronic control and power source 115 .
- FIG. 10 a also shows adjustment tool 121 for adjusting the volume of the intragastric balloon 109 .
- FIGS. 10 a and 10 b utilizes a deflation mechanism for separating the entire valve capsule from the remaining portion of the balloon.
- the valve capsule 111 When inflated, the valve capsule 111 is held tightly in the balloon collar 114 by pressure exerted by shape memory torsional spring 113 , creating a seal between the valve capsule and the balloon collar.
- the patient may be brought into the physician's office in an outpatient setting.
- the physician activates the valve opening mechanism remotely and from outside the body, using a remote control 100 ( FIG. 9 ).
- the physician holds remote control 100 near the stomach of the patient, and upon depression of a button, remote control 100 sends an activation signal to the combined microelectronic control and power source 115 .
- Combined microelectronic control and power supply 115 has an antenna (not shown) for receiving the activation signal from remote control 100 .
- combined microelectronic control and power source uses power to begin increasing the temperature of heating element(s) (not shown) that are connected to the torsional spring 113 .
- metal film heating elements utilizing materials such as nichrome, stainless steel, copper, gold, or other such materials, can be used for the heating element(s).
- the temperature of shape memory torsional spring 113 also begins to increase, thereby causing the spring to deform and reduce in diameter. As the diameter decreases, the seal between valve capsule 111 and balloon collar 114 is broken.
- the combined microelectronic control and power supply 115 may communicate with the remote control 100 to confirm that the deflation mechanism has been activated. Following receipt of a confirmation signal, the physician and patient may then track the progress of the passing of the device.
- FIG. 11 another preferred embodiment of an intragastric balloon of the present invention incorporating a remote deflation mechanism is shown.
- Intragastric balloon 129 is comprised of shell 130 and valve capsule 131 .
- Valve capsule 131 is comprised of valve 132 , and combined microelectronic control and power source 135 .
- Shell 130 is comprised of a collar 136 , heating element 137 , and shape memory cutting element 138 .
- FIG. 11 also shows adjustment tool 141 for adjusting the volume of the intragastric balloon 129 .
- the embodiment of the present invention shown in FIG. 11 utilizes a deflation mechanism for separating the entire valve capsule from the remaining portion of the balloon.
- the valve capsule 131 When inflated, the valve capsule 131 is held tightly in the balloon collar 114 by pressure exerted by shape memory element 138 , creating a seal between the valve capsule and the balloon collar.
- the patient may be brought into the physician's office in an outpatient setting.
- the physician activates the valve opening mechanism remotely and from outside the body, using a remote control 100 ( FIG. 9 ).
- the physician holds remote control 100 near the stomach of the patient, and upon depression of a button, remote control 100 sends an activation signal to the combined microelectronic control and power source 135 .
- Combined microelectronic control and power supply 135 has an antenna (not shown) for receiving the activation signal from remote control 100 .
- combined microelectronic control and power source uses power to begin increasing the temperature of heating element(s) 137 that are connected to the shape memory cutting element 138 .
- metal film heating elements utilizing materials such as nichrome, stainless steel, copper, gold, or other such materials, can be used for the heating element(s).
- the temperature of shape memory cutting element 138 also begins to increase, thereby causing the cutting element to cut through the balloon collar 136 . With the balloon collar 136 completely cut, the seal between valve capsule 131 and balloon collar 136 is broken.
- the remote deflation mechanism may be comprised of a mechanical system (such as a torsional spring) contained within the collar which holds the valve capsule in place until the balloon deflation mechanism is initiated.
- the combined microelectronic control and power supply 135 may communicate with the remote control 100 to confirm that the deflation mechanism has been activated. Following receipt of a confirmation signal, the physician and patient may then track the progress of the passing of the device.
- the intragastric balloon of the present invention may be constructed of a very thin, highly acid-resistant shell material.
- the intragastric balloon may be shaped to encourage collapse into a bullet shape for smooth passage through the intestines. This shape may be created by pre-formed convolutions in the shell that would expand into a substantially spherical or ellipsoidal shape when inflated, but would retract into its small collapsed shape when the remote deflation mechanism was triggered.
- the remote control will take the form of a handheld control unit that may feature an LCD display and/or similar type of display and a control panel, such as a keyboard or touchscreen, to operate the device.
- the remote control may feature a series of menus that allow an operator to program (or read/determine) the microelectronics to contain in memory important information such as the intragastric balloon's size, patient's name, implanting physician, and the date it was implanted.
- the remote control may communicate with the sensor via telemetry through radiowaves.
- the FDA and globally recognized communications band may be used in some embodiments, and an authentication process (e.g., digital handshake signal, PIN verification, or other similar verification process) can be used to ensure that the device cannot be accidentally accessed or controlled by another control mechanism other than the remote control.
- the telemetry control signal can be sent from approximately a foot or possibly a greater distance from the patient and will typically not require the patient to disrobe to query the sensor or to change its parameters.
- the remote control is preferably able to read and write information to the microelectronics contained in the intragastric balloon.
- the remote control may also be password controlled to prevent unauthorized personnel from querying the device.
- the display of the remote control which may include visual and audio outputs, typically will display or output the sensed parameter of the remote deflation valve's condition or physical parameter whether this parameter is “open”, “closed”, or any other physical parameter that the remote control is adjusted to monitor.
- the patient is an overweight male who has previously had an intragastric balloon inserted into his stomach.
- the intragastric balloon has been implanted for a full course of treatment for six months, and the surgeon is prepared to remove the balloon.
- the removal of the balloon is performed in an outpatient setting at the doctor's office. Reference is made to FIGS. 2 a and 2 b for the remote deflation valve utilized in this example.
- the physician activates the remote deflation mechanism from outside the body using a remote control 100 , such as that depicted in FIG. 9 .
- the physician holds remote control 100 near the stomach of the patient, and upon depression of a button, remote control 100 sends an activation signal through the patient's tissue to the microelectronic control 32 .
- microelectronic control 32 Upon receiving the activation signal, microelectronic control 32 uses power from a battery 33 to begin increasing the temperature of heating element(s) 31 . As the temperature of heating element(s) 31 begins to increase, the wax plug 30 begins to melt.
- wicking surfaces 34 As the wax begins to melt, it collects on wicking surfaces 34 . The collection of the wax on wicking surfaces 34 prevents the wax from clogging capillaries 35 and allows the fluid contained within intragastric balloon 10 to flow out of the balloon. Once the wax is melted and collected on wicking surfaces 34 , capillaries 35 allow the free flow of the fluid contained inside the balloon through valve opening 36 . In addition, once the wax is melted, the microelectronic control 32 sends a confirmation signal to the remote control 100 , informing the doctor and patient that the deflation device has been activated.
- the balloon drains of the saline contained inside and shrinks down to a size that is passable through the human body.
- the microelectronics, heating elements, and battery are safely contained within the valve structure such that they do not present any danger to the patient.
- the patient may now leave the doctor's office and return home.
- the patient tracks the passage of the intragastric balloon and informs the doctor when it has passed.
- the patient is an overweight female who has previously had an intragastric balloon implanted. After implantation the patient has experienced significant undesired side effects resulting from the implantation, including nausea, vomiting, and general abdominal discomfort. Therefore, the patient desires to have the remote deflation mechanism activated, thus allowing the balloon to be passed.
- the balloon removal is performed in an outpatient setting at the doctor's office.
- the physician activates the remote deflation mechanism using a remote control 100 , such as that depicted in FIG. 9 .
- the physician positions remote control 100 near the stomach of the patient, and upon depression of a button, remote control 100 sends an activation signal through the tissue of the abdominal cavity to the microelectronic control 95 .
- Microelectronic control 95 has an antenna for receiving the activation signal from remote control 100 . Upon receiving the activation signal, microelectronic control uses power from battery 96 to begin increasing the temperature of heating element(s) 93 . As the temperature of heating element(s) 93 begins to increase, the temperature of cutting wire 94 also begins to increase. The increased temperature of the cutting wire causes the valve/balloon bond 92 to deteriorate, resulting in separation of the valve 91 from shell 97 .
- the normal movements of the stomach cause the fluid contained inside the balloon to freely flow through the opening 98 .
- the normal movements and contraction of the stomach walls cause the intragastric balloon to completely drain of the fluid contained inside and shrink down to a size that is passable through the human body.
- the microelectronics, heating elements and battery are safely contained within the valve structure such that they do not present any danger to the patient. Because the entire intragastric balloon may now comprise two separate pieces, the passing of the balloon and valve is facilitated.
- the microelectronic control 95 sends a confirmation signal to remote control 100 to confirm that the deflation mechanism has been activated. Following receipt of a confirmation signal by the remote control, the procedure is complete and the patient can return home and wait until the shell and valve assembly pass through the system. The patient tracks the passage of the intragastric balloon and informs the doctor when its has passed.
- the patient is an overweight male who has previously had an intragastric balloon inserted into his stomach.
- the intragastric balloon has been implanted for a full course of treatment for six months, and the surgeon is prepared to remove the balloon.
- FIGS. 10 a and 10 b for the remote deflation valve utilized in this example.
- the physician activates the remote deflation mechanism from outside the body using a remote control 100 , such as that depicted in FIG. 9 .
- the physician holds remote control 100 near the stomach of the patient, and upon depression of a button, remote control 100 sends an activation signal through the patient's tissue to the combined microelectronic control and power source 115 .
- the combined microelectronic control and power source 115 uses power to begin increasing the temperature of heating element(s) (not shown) that are connected to the torsional spring 113 .
- the temperature of the heating element(s) begin to increase, the temperature of shape memory torsional spring 113 also begins to increase, thereby causing the spring to deform and reduce in diameter.
- the seal between valve capsule 111 and balloon collar 114 is broken. The valve capsule is separated from the shell, and fluid contained inside the balloon freely flows through the opening 116 ( FIG. 10 b ) that is created by the separation of the two portions.
- the balloon drains of the saline contained inside and shrinks down to a size that is passable through the human body.
- the combined microelectronics control and power supply and heating element(s) are safely contained within the valve capsule such that they do not present any danger to the patient.
- the patient may now leave the doctor's office and return home.
- the patient tracks the passage of the intragastric balloon and informs the doctor when it has passed.
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nursing (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
An intragastric balloon and apparatus for remote deflation of the balloon are disclosed. The apparatus for remote deflation allows the physician to cause the valve of the intragastric balloon to open without surgery using a remote control from outside of the body. The remote deflation mechanism may be powered internally by a battery or may be powered externally by induction. Additionally, a deflation mechanism that causes the entire valve to be separated from the intragastric balloon is disclosed.
Description
- 1. Field of the Invention
- The present invention is directed to devices and methods that enable remote deflation of intragastric balloons used for the treatment of obesity, and in particular devices and methods that enable an implanted intragastric balloon to be remotely deflated while the device itself is in the stomach.
- 2. Description of the Related Art
- Intragastric balloons are well known in the art as a means for treating obesity. One such inflatable intragastric balloon is described in U.S. Pat. No. 5,084,061 and is commercially available as the BioEnterics Intragastric Balloon System (sold under the trademark BIB®). These devices are designed to provide therapy for moderately obese individuals who need to shed pounds in preparation for surgery, or as part of a dietary or behavioral modification program.
- The BIB System, for example, consists of a silicone elastomer intragastric balloon that is inserted into the stomach and filled with fluid. Commercially available intragastric balloons are filled with saline solution or air. The intragastric balloon functions by filling the stomach and enhancing appetite control. Placement of the intragastric balloon is non-surgical, usually requiring no more than 20-30 minutes. The procedure is performed gastroscopically in an outpatient setting, typically using local anesthesia and sedation. Placement is temporary, and intragastric balloons are typically removed after six months.
- Most intragastric balloons utilized for this purpose are placed in the stomach in an empty or deflated state and thereafter filled (fully or partially) with a suitable fluid. The balloon occupies space in the stomach, thereby leaving less room available for food and creating a feeling of satiety for the patient. Clinical results with these devices show that for many obese patients, the intragastric balloons significantly help to control appetite and accomplish weight loss.
- Intragastric balloons typically are implanted for a finite period of time, usually lasting approximately six months. This time period may be shortened by a treating physician who wishes to alter the patient's treatment and remove the balloon prior to the six month period. In any event, at some point after the balloon has been surgically placed in the stomach, it will become desirable to remove the balloon from the stomach. One of the means of removing the balloon is to deflate it by puncturing the balloon, and either aspirating the contents of the balloon or allowing the fluid to pass into the patient's stomach. This means of removing saline from the balloon requires surgical intervention, through the use of a gastroscopic instrument. When the balloon is deflated in this manner, the balloon itself may be surgically removed using the gastroscopic instrument.
- Alternatively, if the balloon is left in place beyond its designed lifetime, the acids present in a patient's stomach may erode the balloon to the point where it self-deflates. When this occurs, the deflated balloon may pass naturally through the patient's digestive system and be expelled through the bowel.
- Those experienced in the art will readily appreciate that manipulating the balloon in situ in order to deflate the balloon can be difficult. This is because the balloon is slippery and positionally unstable. The usually spherical or ellipsoidal intragastric balloons may readily rotate in the stomach, making it difficult for a surgeon to manipulate the balloon in order to find a deflation valve, or to safely puncture the balloon using a surgical instrument.
- It may become desirable, then, particularly when the balloon is to be removed from the body, to cause the deflation of the balloon remotely without surgical intervention.
- Therefore, the present invention is directed at overcoming the problems associated with the prior art systems. These and other objects of the present invention will become apparent from the further disclosure to be made in the detailed descriptions given below.
- The present invention addresses the above-described problems by providing apparatuses and methods for the remote deflation of an intragastric balloon. The present invention allows a physician to remotely deflate an intragastric balloon from outside the body, utilizing a remote control that triggers the deflation with an activation signal.
- In one preferred embodiment, the apparatus of the present invention includes a meltable wax plug that melts to cause the opening of a valve. Upon receipt of an activation signal sent by the physician from a remote control outside the body, the microelectronics contained in the valve assembly cause the temperature of heating element(s) contained within the valve to melt the wax plug. Once the wax plug has melted, thus causing the balloon valve to open, the normal movements of the stomach cause the fluid contained within the balloon to empty from the balloon, causing deflation. The patient is able to then pass the balloon.
- In another preferred embodiment, the apparatus of the present invention includes a remote deflation valve having a shape memory element spring that holds a plug in place, thus sealing the valve of the intragastric balloon. The shape memory element spring may be heated remotely by induction, or the deflation mechanism may include microelectronics to cause heating of the spring. As the spring changes shape as a result of the application of heat, it removes the plug, thus causing the balloon to unseal. The fluid contained in the balloon may then flow freely out of the balloon, thus causing the balloon to deflate. The patient is then able to safely pass the deflated balloon.
- According to yet another embodiment of the present invention, the intragastric balloon includes a remote deflation mechanism with a shape memory element actuator, a spring collar, an obstruction that holds the spring collar in place and a slit valve. As with the other embodiments disclosed, the shape memory element actuator may be heated remotely by induction or may alternatively include microelectronics and heating elements contained within the deflation mechanism. When the deflation mechanism is activated, the actuator pushes the obstruction out of the valve, thus allowing the spring collar to contract. The contraction of the spring collar causes the slit valve to open, which allows fluid contained in the balloon to flow out of the balloon and drain accordingly. The patient is then able to pass the deflated balloon.
- In another preferred embodiment of the present invention, a shape memory element “cutting wire” is employed in the remote deflation mechanism. In this embodiment, when heat is applied to the shape memory alloy wire contained within a remote deflation valve, the wire changes shape, causing the wire to cut through a wax (or other suitable material, e.g. plastic or polymer) plug that seals the valve. Once the wax plug has been cut from the valve, fluid is able to freely flow through the valve, thus allowing the balloon to drain and pass from the body.
- In still yet another preferred embodiment of the present invention, the remote deflation mechanism of the intragastric balloon includes a wire that surrounds the valve. The wire is used to break the bond between the valve and the balloon. When the bond between balloon and the valve is broken, the valve separates from the balloon, and fluid flows freely from the balloon. This preferred embodiment has the added benefit that the balloon and valve assembly may pass through the body separately, thus allowing passage to occur more easily, as the device is in two separate pieces. These and various other aspects of the invention, and its advantages, will be discussed in more detail below.
- In another embodiment, the valve could be contained in a cylindrical capsule (taking the shape of a large pill, for example) that fits within a collared opening of the balloon shell to create a seal. The collared opening could include a spring or other such mechanism that would retain the size and shape of the collar. When the remote deflation mechanism is activated, the spring is released, thereby opening the collar and ejecting the cylindrical capsule from the balloon, rendering two separate components that could then easily pass through the gastrointestinal track. Alternatively, the collared opening could include a heating element, which when the remote deflation mechanism is activated, would cause the seal between the capsule and the collar to break, thereby ejecting the cylindrical capsule from the balloon. As yet a further alternative, the cylindrical capsule could contain a mechanism such as a spring (a torsional spring, for example), that retains the shape and size of the capsule, holding the capsule in place within the collared opening of the balloon shell. When the remote deflation mechanism is activated, the torsional spring collapses, causing the capsule to be ejected from the balloon.
-
FIG. 1 is an elevated side view of an intragastric balloon of the present invention. -
FIG. 2 a is a side cut-away view of a remote deflation valve according to one embodiment of the present invention, which shows the valve in the “closed” position. -
FIG. 2 b is a side cut-away view of the remote deflation valve ofFIG. 2 a shown in the “open” position. -
FIG. 3 a is a side cut-away view of a remote deflation valve according to a further embodiment of the present invention, which shows the valve in the “closed” position. -
FIG. 3 b is a side cut-away view of the remote deflation valve ofFIG. 3 a shown in the “open” position. -
FIG. 4 a is a side view of a remote deflation valve according to yet a further embodiment of the present invention, which shows the valve in the “closed” position. -
FIG. 4 b is a side cut-away view of the remote deflation valve ofFIG. 4 a shown in the “open” position. -
FIG. 5 a is a side view of the remote deflation valve ofFIG. 4 a which shows the valve in the “closed” position. -
FIG. 5 b is a side view of the remote deflation valve ofFIG. 4 b shown in the “open” position. -
FIG. 6 a is a side cut-away view of a remote deflation valve according to still a further embodiment of the present invention, which shows the valve in the “closed” position. -
FIG. 6 b is a side cut-away view of the remote deflation valve ofFIG. 6 a shown in the “open” position. -
FIGS. 7 a and 7 b show a top view of an embodiment of the wire cutting mechanism of the remote deflation valve ofFIGS. 6 a and 6 b. -
FIGS. 7 c and 7 d show a further embodiment of the wire cutting mechanism of the remote deflation valve ofFIGS. 6 a and 6 b. -
FIG. 8 a shows an elevated side view of an intragastric balloon of the present invention with a deflation mechanism surrounding the valve prior to the deflation mechanism being activated. -
FIG. 8 b shows an elevated side view ofFIG. 8 a after the deflation mechanism has been activated. -
FIG. 9 is a front view of a remote control for activating a remote deflation valve according to the present invention. -
FIG. 10 a is a side cut-away view of a remote-deflating intragastric balloon according to still a further embodiment of the present invention, which shows the balloon in the “closed” position. -
FIG. 10 b is a side cut-away view of the remote-deflating intragastric balloon ofFIG. 10 a shown in the “open” position. -
FIG. 11 is a side cut-away view of a remote-deflating intragastric balloon according to still a further embodiment of the present invention, which shows the balloon in the “closed” position. - The present invention is directed to a method and device for remotely deflating an intragastric balloon without requiring surgical intervention.
- Referring to
FIGS. 1-2 b, the intragastric balloon according to one preferred embodiment of the present invention is shown. Theintragastric balloon 10 includes ashell 12, fillvalve 14, andremote deflation valve 16. - During implantation, an
un-inflated balloon 10 may be positioned in the stomach in a desired location. Once the balloon is positioned, it may be inflated usingfill valve 14, and those experienced in the art will appreciate that there are several different methods for inflating the balloon, such as disclosed in commonly assigned International Application Number PCT U.S. 03/19414, entitled “Two Way Slit Valve”, the disclosure of which is incorporated in its entirety herein by reference. - After implantation, it may become desirable to remove the balloon. In order to remove the balloon it must first be deflated. Once deflated, the balloon may be allowed to naturally pass through the body upon deflation, or alternatively the balloon may be surgically removed using a minimally invasive gastroscopic procedure. The present invention is designed such that the deflated intragastric balloon and integrated remote deflation valve may naturally pass through the human body.
- Referring to
FIGS. 2 a and 2 b, a preferred embodiment of the remote deflation valve of the present invention is shown.Remote deflation valve 16 is comprised of sealingplug 30, heating element(s) 31,microelectronic control 32 andpower source 33. Thepower source 33 may be a battery, capacitor, induction coil, kinetic energy creation by body motion stored onto a capacitor, fuel cell, power source powered by chemistry of the body, or a power source powered by temperature change. The sealingplug 30 is preferably formed of suitable medical-grade wax, such as paraffin, or may also be a lower temperature melt polymer. Any type of suitable medical-grade wax, such as paraffin, may be used for sealingplug 30. - At the time the physician desires to deflate the balloon, the patient may be brought into the physician's office in an outpatient setting. In order to open
deflation valve 16, the physician activates the valve opening mechanism remotely and from outside the body, using aremote control 100 such as that depicted inFIG. 9 . The physician holdsremote control 100 near the stomach of the patient, and upon depression ofbutton 101,remote control 100 sends an activation signal, which my be comprised of radio waves, sonic waves, or any other waves suitable for transmitting a small activation signal through the tissue of the abdominal cavity to the implanted balloon. -
Microelectronic control 32 has an antenna (not shown) for receiving the activation signal fromremote control 100. Upon receiving the activation signal, microelectronic control uses power frompower source 33 to begin increasing the temperature of the heating element(s) 31. A metal film heating element, utilizing metals (such as nichrome, stainless steel, copper, gold, etc.) can be used for heating element(s) 31. As the temperature of the heating element(s) 31 begins to increase, the sealingplug 30 begins to melt. Ideally, the melting point of the sealing plug will be slightly above the temperatures in the stomach to ensure that the valve stays closed in its normal operating environment. - As the sealing plug begins to melt, it is expelled into the stomach and/or collects on wicking surfaces 34, which may be composed of a contoured reservoir. Ideally the wax will melt and be expelled into the stomach for rapid quench cooling and passage through the intestines. The collection of the wax or other sealing material on wicking surfaces 34 prevents it from clogging
capillaries 35 and allows the fluid contained withinintragastric balloon 10 to flow out of the balloon. Once the sealing plug is completely melted and been expelled into the stomach and/or collected on wicking surfaces 34,capillaries 35 allow the free flow of the fluid contained inside the balloon through valve opening 36 (FIG. 2 b). Through the normal movements and contraction of the stomach walls, the balloon will drain of the fluid contained inside and shrink down to a size that is passable through the body. The microelectronics, heating element, and power source are safely contained within the valve structure such that they do not present any danger to the patient. - In addition to performing the function of controlling the heating element for the melting of the sealing plug, the
microelectronic control 32 may communicate with theremote control 100 to confirm that the deflation mechanism has been activated. Following receipt of a confirmation signal, the physician and patient may then track the progress of the passing of the device. - Referring to
FIGS. 3 a and 3 b, another preferred embodiment of the remote deflation valve of the present invention is shown.Remote deflation valve 26 is comprised of ashape memory spring 41, plug 42, andcapillaries 43. While NiTiNOL is the preferred material for the spring utilized in the present invention, any number of shape memory alloys or polymers, or spring materials, including steels (such as stainless steel, chromium, titanium, etc.), may be used. - As with the valve mechanism discussed in the previous embodiment, at the time the physician desires to deflate the balloon, the patient may be brought into the physician's office in an outpatient setting.
- In order to open
deflation valve 26, the physician activates the deflation mechanism from outside the body, using a remote control (not shown). The spring may be heated remotely by induction from the remote control, or may alternatively include microelectronics for receiving an activation signal and controlling heating elements similar to those described in the previous embodiment. - Irrespective of the method of activation, when the
spring 41 is heated, it contracts, pulling theplug 42 out of its resting place and intoreservoir 44. This causeschannel 45 to open, thus allowing the fluid contained in the balloon to flow through thecapillaries 43 andopen channel 45, out of the balloon.FIG. 3 b shows the valve mechanism in its open position. Because of pressure normally exerted on the balloon by the stomach, the fluid contained therein will flow freely through the capillaries and open channel and into the stomach, thus causing the balloon to deflate. The deflated intragastric balloon is then allowed to pass out of the body. - As an alternative to having a shape memory spring permanently fixed to a plug, the spring may be detachably fixed to a plug comprised of wax or some other similar biodegradable material. In this way, when the spring is heated and changes shape, it may be used to eject the biodegradable plug into the stomach, thus allowing the balloon to drain. The deflated intragastric balloon would then be allowed to pass out of the body.
- Referring to
FIGS. 4 a, 4 b, 5 a, and 5 b, another preferred embodiment of a remote deflation valve of the present invention is shown.FIGS. 4 a and 4 b show a cutaway side view ofremote deflation valve 56, whileFIGS. 5 a and 5 b show the same valve in a side view.Remote deflation valve 56 is comprised of ashape memory actuator 61,obstruction 62, slitvalve 63 andspring collar 64. As previously discussed, while NiTiNOL is the preferred material for the actuator of the present invention, any number of shape memory alloys or polymers may be used. - In order to open
deflation valve 56, the physician activates the valve opening mechanism remotely and from outside the body, usingremote control 100. Theactuator 61 may be heated remotely by induction or alternatively the remote deflation valve may include microelectronics and heating elements. - Irrespective of the method of activation, the
actuator 61, when activated, pushesobstruction 62 out of the valve opening. When in place,obstruction 62 serves to prevent theslit valve 63 from opening by causingspring collar 64 to be held in its open position, as shown inFIGS. 4 a and 5 a. Once theobstruction 62 is removed from the valve opening,spring collar 64, which is located below theslit valve 63, contracts. The contraction ofspring collar 64 causes theslit valve 63 to be opened, as shown inFIG. 4 b and 5 b. With theslit valve 63 now open, the fluid contained in the balloon may flow throughchannel 65 and out through theslit valve opening 66. Again, because the intragastric balloon is under pressure, and due to the normal movements of the stomach, the fluid contained therein will flow freely throughopen slit valve 63 and into the stomach, thus causing the balloon to deflate. The deflated intragastric balloon is then allowed to pass out of the body. - Referring to
FIGS. 6 a and 6 b, an interior cutaway view of another preferred embodiment of the remote deflation valve of the present invention is shown.Remote deflation valve 76 is comprised of a shape memory alloycutting wire mechanism 81, sealingplug 82, andcapillary 83. NiTiNOL is used in this preferred embodiment, however, any number of suitable shape memory alloys may be used. - As with the previous embodiments discussed, in order to open
valve 76, the physician activates the valve opening mechanism remotely and from outside the body, using remote control 100 (FIG. 9 ). In this embodiment, theremote deflation valve 76 includes microelectronics (not shown), a battery or other power source (not shown) and heating element(s) 85 (FIGS. 7 a-7 d) for heating the shape memory alloy cutting wire 84 (FIGS. 7 a-7 d). As with the previous embodiments discussed, however, the shape memory alloy cutting wire may be heated by induction. -
FIGS. 7 a, 7 b, 7 c, and 7 d show top views of thecutting wire mechanism 84. As heat is applied by the heating elements, the shape memory element begins to change shape.FIG. 7 a shows the shape memoryelement cutting wire 84 prior to the application of heat. Prior to the application of heat, the shape memoryelement cutting wire 84 is in a curved L-shape, with the curved portion resting around the outside ofwax plug 82. As an alternative to the L-shaped shape memoryelement cutting wire 84 ofFIG. 7 a, the cutting wire may also be in a loop shape that completely encircles the wax plug, as is shown inFIG. 7 c. - In this embodiment, the shape memory element
cutting wire mechanism 81 is activated by a signal received from remote control 100 (FIG. 9 ). Upon receiving the activation signal, the microelectronic control (not shown) uses power from the power source (not shown) to begin increasing the temperature of heating element(s) 85. As the shape memoryelement cutting wire 84 begins to change shape as a result of the application of heat, it slices through the sealingplug 82.FIGS. 7 b and 7 d show the shape memoryalloy cutting wire 84 in its post-heat application deformed shape, having cut through the sealingplug 82.FIG. 7 a shows a shape memory alloy cutting wire in an L-shaped configuration, whileFIG. 7 c shows a shape memory alloy cutting wire in a loop shaped configuration. - With the sealing
plug 82 having been severed from the valve, the capillary 83 (FIG. 6 b) is now open to allow fluid contained within the intragastric balloon to escape the balloon. Again, because the intragastric balloon is under pressure and due to the normal movements of the stomach, the fluid contained in the balloon will flow freely through the capillary and into the stomach, thus causing the balloon to deflate. The deflated intragastric balloon is then allowed to pass out of the body. - Referring to
FIGS. 8 a and 8 b, another preferred embodiment of an intragastric balloon of the present invention incorporating a remote deflation mechanism is shown.Intragastric balloon 90 is comprised ofshell 97,valve 91, valve/balloon bond 92,heating elements 93, cutting wire 94,microelectronic control 95, andpower source 96. - Rather than using a remote deflation mechanism to open the valve of the intragastric balloon, the embodiment of the present invention shown in
FIGS. 8 a and 8 b utilizes a deflation mechanism for separating the entire valve from the remaining portion of the balloon. - Similar to the procedures described above, at the time the physician desires to deflate the balloon, the patient may be brought into the physician's office in an outpatient setting. In order to cause the
intragastric balloon 90 to deflate, the physician activates the valve opening mechanism remotely and from outside the body, using a remote control 100 (FIG. 9 ). The physician holdsremote control 100 near the stomach of the patient, and upon depression of a button,remote control 100 sends an activation signal to themicroelectronic control 95. -
Microelectronic control 95 has an antenna (not shown) for receiving the activation signal fromremote control 100. Upon receiving the activation signal, microelectronic control uses power frompower source 96 to begin increasing the temperature of heating element(s) 93. Similar to the embodiments discussed above that incorporate heating elements, metal film heating elements utilizing materials such as nichrome, stainless steel, copper, gold, or other such materials, can be used for heating element(s) 93. As the temperature of heating element(s) 93 begin to increase, the temperature of cutting wire 94 also begins to increase. The increased temperature of the cutting wire causes the valve/balloon bond 92 to deteriorate, resulting in separation of thevalve 91 fromshell 97. - Once the valve/
balloon bond 92 is broken and the valve is separated from the shell, fluid contained inside the balloon freely flows through theopening 98 that is created by the separation of the two portions. Through the normal movements and contraction of the stomach walls, the balloon will drain of the fluid contained inside and shrink down to a size that is passable through the human body. The microelectronics, heating element(s) and power source are safely contained within the valve structure such that they do not present any danger to the patient. Because the entire intragastric balloon may now be in two separate pieces—an empty shell and a self-contained valve assembly—the passing of the balloon and valve is facilitated. - As with the previous embodiments described, in addition to performing the function of controlling the heating elements, the
microelectronic control 95 may communicate with theremote control 100 to confirm that the deflation mechanism has been activated. Following receipt of a confirmation signal, the physician and patient may then track the progress of the passing of the device. - Referring to
FIGS. 10 a and 10 b, another preferred embodiment of an intragastric balloon of the present invention incorporating a remote deflation mechanism is shown.Intragastric balloon 109 is comprised ofshell 110 and valve capsule 111. Valve capsule 111 is comprised of valve 112, shape memorytorsional spring 113, and combined microelectronic control andpower source 115.FIG. 10 a also showsadjustment tool 121 for adjusting the volume of theintragastric balloon 109. - Rather than using a remote deflation mechanism to open the valve of the intragastric balloon, the embodiment of the present invention shown in
FIGS. 10 a and 10 b utilizes a deflation mechanism for separating the entire valve capsule from the remaining portion of the balloon. When inflated, the valve capsule 111 is held tightly in theballoon collar 114 by pressure exerted by shape memorytorsional spring 113, creating a seal between the valve capsule and the balloon collar. - Similar to the various procedures described above, at the time the physician desires to deflate the balloon, the patient may be brought into the physician's office in an outpatient setting. In order cause the
intragastric balloon 109 to deflate, the physician activates the valve opening mechanism remotely and from outside the body, using a remote control 100 (FIG. 9 ). The physician holdsremote control 100 near the stomach of the patient, and upon depression of a button,remote control 100 sends an activation signal to the combined microelectronic control andpower source 115. - Combined microelectronic control and
power supply 115 has an antenna (not shown) for receiving the activation signal fromremote control 100. Upon receiving the activation signal, combined microelectronic control and power source uses power to begin increasing the temperature of heating element(s) (not shown) that are connected to thetorsional spring 113. Similar to the embodiments discussed above that incorporate heating elements, metal film heating elements utilizing materials such as nichrome, stainless steel, copper, gold, or other such materials, can be used for the heating element(s). As the temperature of the heating element(s) begin to increase, the temperature of shape memorytorsional spring 113 also begins to increase, thereby causing the spring to deform and reduce in diameter. As the diameter decreases, the seal between valve capsule 111 andballoon collar 114 is broken. - Once the seal between the
balloon collar 114 and valve capsule 111 is broken and the valve capsule is separated from the shell, fluid contained inside the balloon freely flows through the opening 116 (FIG. 10 b) that is created by the separation of the two portions. Through the normal movements and contraction of the stomach walls, the balloon will drain of the fluid contained inside and shrink down to a size that is passable through the human body. The combined microelectronic control and power supply and heating element(s) are safely contained within the valve capsule such that they do not present any danger to the patient. Because the entire intragastric balloon may now be in two separate pieces—an empty shell and a self-contained valve capsule—the passing of the balloon and valve is facilitated. - As with the previous embodiments described, in addition to performing the function of controlling the heating elements, the combined microelectronic control and
power supply 115 may communicate with theremote control 100 to confirm that the deflation mechanism has been activated. Following receipt of a confirmation signal, the physician and patient may then track the progress of the passing of the device. - Referring to
FIG. 11 , another preferred embodiment of an intragastric balloon of the present invention incorporating a remote deflation mechanism is shown. Intragastric balloon 129 is comprised ofshell 130 andvalve capsule 131.Valve capsule 131 is comprised ofvalve 132, and combined microelectronic control andpower source 135.Shell 130 is comprised of a collar 136, heating element 137, and shapememory cutting element 138.FIG. 11 also showsadjustment tool 141 for adjusting the volume of the intragastric balloon 129. - As with several of the other embodiments previously discussed, rather than using a remote deflation mechanism to open the valve of the intragastric balloon, the embodiment of the present invention shown in
FIG. 11 utilizes a deflation mechanism for separating the entire valve capsule from the remaining portion of the balloon. When inflated, thevalve capsule 131 is held tightly in theballoon collar 114 by pressure exerted byshape memory element 138, creating a seal between the valve capsule and the balloon collar. - Similar to the various procedures described above, at the time the physician desires to deflate the balloon, the patient may be brought into the physician's office in an outpatient setting. In order cause the intragastric balloon 129 to deflate, the physician activates the valve opening mechanism remotely and from outside the body, using a remote control 100 (
FIG. 9 ). The physician holdsremote control 100 near the stomach of the patient, and upon depression of a button,remote control 100 sends an activation signal to the combined microelectronic control andpower source 135. - Combined microelectronic control and
power supply 135 has an antenna (not shown) for receiving the activation signal fromremote control 100. Upon receiving the activation signal, combined microelectronic control and power source uses power to begin increasing the temperature of heating element(s) 137 that are connected to the shapememory cutting element 138. Similar to the embodiments discussed above that incorporate heating elements, metal film heating elements utilizing materials such as nichrome, stainless steel, copper, gold, or other such materials, can be used for the heating element(s). As the temperature of the heating element(s) begin to increase, the temperature of shapememory cutting element 138 also begins to increase, thereby causing the cutting element to cut through the balloon collar 136. With the balloon collar 136 completely cut, the seal betweenvalve capsule 131 and balloon collar 136 is broken. - Once the seal between the balloon collar 136 and
valve capsule 131 is broken and the valve capsule is separated from the shell, fluid contained inside the balloon freely flows through the opening that is created by the separation of the two portions. Through the normal movements and contraction of the stomach walls, the balloon will drain of the fluid contained inside and shrink down to a size that is passable through the human body. The combined microelectronic control and power supply and heating element(s) are safely contained within the valve capsule such that they do not present any danger to the patient. Because the entire intragastric balloon may now be in two separate pieces—an empty shell and a self-contained valve capsule—the passing of the balloon and valve is facilitated. As an alternative to the cutting mechanism described herein, the remote deflation mechanism may be comprised of a mechanical system (such as a torsional spring) contained within the collar which holds the valve capsule in place until the balloon deflation mechanism is initiated. - As with the previous embodiments described, in addition to performing the function of controlling the heating elements, the combined microelectronic control and
power supply 135 may communicate with theremote control 100 to confirm that the deflation mechanism has been activated. Following receipt of a confirmation signal, the physician and patient may then track the progress of the passing of the device. - To ensure the device of the present invention will pass easily, the intragastric balloon of the present invention may be constructed of a very thin, highly acid-resistant shell material. In addition, the intragastric balloon may be shaped to encourage collapse into a bullet shape for smooth passage through the intestines. This shape may be created by pre-formed convolutions in the shell that would expand into a substantially spherical or ellipsoidal shape when inflated, but would retract into its small collapsed shape when the remote deflation mechanism was triggered.
- The remote control will take the form of a handheld control unit that may feature an LCD display and/or similar type of display and a control panel, such as a keyboard or touchscreen, to operate the device. The remote control may feature a series of menus that allow an operator to program (or read/determine) the microelectronics to contain in memory important information such as the intragastric balloon's size, patient's name, implanting physician, and the date it was implanted. The remote control may communicate with the sensor via telemetry through radiowaves. The FDA and globally recognized communications band (WMTS 402-405 Mhz) may be used in some embodiments, and an authentication process (e.g., digital handshake signal, PIN verification, or other similar verification process) can be used to ensure that the device cannot be accidentally accessed or controlled by another control mechanism other than the remote control. The telemetry control signal can be sent from approximately a foot or possibly a greater distance from the patient and will typically not require the patient to disrobe to query the sensor or to change its parameters. The remote control is preferably able to read and write information to the microelectronics contained in the intragastric balloon. The remote control may also be password controlled to prevent unauthorized personnel from querying the device. The display of the remote control, which may include visual and audio outputs, typically will display or output the sensed parameter of the remote deflation valve's condition or physical parameter whether this parameter is “open”, “closed”, or any other physical parameter that the remote control is adjusted to monitor.
- The following examples describe various procedures using the method and device of the present invention.
- In this example, the patient is an overweight male who has previously had an intragastric balloon inserted into his stomach. The intragastric balloon has been implanted for a full course of treatment for six months, and the surgeon is prepared to remove the balloon.
- The removal of the balloon is performed in an outpatient setting at the doctor's office. Reference is made to
FIGS. 2 a and 2 b for the remote deflation valve utilized in this example. - In order to open
deflation valve 16, the physician activates the remote deflation mechanism from outside the body using aremote control 100, such as that depicted inFIG. 9 . The physician holdsremote control 100 near the stomach of the patient, and upon depression of a button,remote control 100 sends an activation signal through the patient's tissue to themicroelectronic control 32. - Upon receiving the activation signal,
microelectronic control 32 uses power from abattery 33 to begin increasing the temperature of heating element(s) 31. As the temperature of heating element(s) 31 begins to increase, thewax plug 30 begins to melt. - As the wax begins to melt, it collects on wicking surfaces 34. The collection of the wax on wicking surfaces 34 prevents the wax from clogging
capillaries 35 and allows the fluid contained withinintragastric balloon 10 to flow out of the balloon. Once the wax is melted and collected on wicking surfaces 34,capillaries 35 allow the free flow of the fluid contained inside the balloon throughvalve opening 36. In addition, once the wax is melted, themicroelectronic control 32 sends a confirmation signal to theremote control 100, informing the doctor and patient that the deflation device has been activated. - Through the normal movements and contraction of the stomach walls, the balloon drains of the saline contained inside and shrinks down to a size that is passable through the human body. The microelectronics, heating elements, and battery are safely contained within the valve structure such that they do not present any danger to the patient.
- Having received the confirmation signal, the patient may now leave the doctor's office and return home. The patient tracks the passage of the intragastric balloon and informs the doctor when it has passed.
- In this example, the patient is an overweight female who has previously had an intragastric balloon implanted. After implantation the patient has experienced significant undesired side effects resulting from the implantation, including nausea, vomiting, and general abdominal discomfort. Therefore, the patient desires to have the remote deflation mechanism activated, thus allowing the balloon to be passed.
- As with the first example, the balloon removal is performed in an outpatient setting at the doctor's office. Reference is made to
FIGS. 8 a and 8 b for the remote deflation mechanism utilized in this example. - In order to cause the
intragastric balloon 90 to deflate, the physician activates the remote deflation mechanism using aremote control 100, such as that depicted inFIG. 9 . The physician positionsremote control 100 near the stomach of the patient, and upon depression of a button,remote control 100 sends an activation signal through the tissue of the abdominal cavity to themicroelectronic control 95. -
Microelectronic control 95 has an antenna for receiving the activation signal fromremote control 100. Upon receiving the activation signal, microelectronic control uses power frombattery 96 to begin increasing the temperature of heating element(s) 93. As the temperature of heating element(s) 93 begins to increase, the temperature of cutting wire 94 also begins to increase. The increased temperature of the cutting wire causes the valve/balloon bond 92 to deteriorate, resulting in separation of thevalve 91 fromshell 97. - As the valve/
balloon bond 92 breaks and separates from the shell, the normal movements of the stomach cause the fluid contained inside the balloon to freely flow through theopening 98. The normal movements and contraction of the stomach walls cause the intragastric balloon to completely drain of the fluid contained inside and shrink down to a size that is passable through the human body. The microelectronics, heating elements and battery are safely contained within the valve structure such that they do not present any danger to the patient. Because the entire intragastric balloon may now comprise two separate pieces, the passing of the balloon and valve is facilitated. - Once the valve/balloon bond has been broken, the
microelectronic control 95 sends a confirmation signal toremote control 100 to confirm that the deflation mechanism has been activated. Following receipt of a confirmation signal by the remote control, the procedure is complete and the patient can return home and wait until the shell and valve assembly pass through the system. The patient tracks the passage of the intragastric balloon and informs the doctor when its has passed. - Although the invention has been described and illustrated with a certain degree of particularity, it is understood that the present disclosure has been made only by way of example, and that numerous changes in the combination and arrangement of parts can be resorted to by those skilled in the art without departing from the spirit and scope of the invention, as hereinafter claimed.
- In this example, the patient is an overweight male who has previously had an intragastric balloon inserted into his stomach. The intragastric balloon has been implanted for a full course of treatment for six months, and the surgeon is prepared to remove the balloon.
- The removal of the balloon is performed in an outpatient setting at the doctor's office. Reference is made to
FIGS. 10 a and 10 b for the remote deflation valve utilized in this example. - In order to deflate
balloon 109, the physician activates the remote deflation mechanism from outside the body using aremote control 100, such as that depicted inFIG. 9 . The physician holdsremote control 100 near the stomach of the patient, and upon depression of a button,remote control 100 sends an activation signal through the patient's tissue to the combined microelectronic control andpower source 115. - Upon receiving the activation signal, the combined microelectronic control and
power source 115 uses power to begin increasing the temperature of heating element(s) (not shown) that are connected to thetorsional spring 113. As the temperature of the heating element(s) begin to increase, the temperature of shape memorytorsional spring 113 also begins to increase, thereby causing the spring to deform and reduce in diameter. As the diameter decreases, the seal between valve capsule 111 andballoon collar 114 is broken. The valve capsule is separated from the shell, and fluid contained inside the balloon freely flows through the opening 116 (FIG. 10 b) that is created by the separation of the two portions. - Through the normal movements and contraction of the stomach walls, the balloon drains of the saline contained inside and shrinks down to a size that is passable through the human body. The combined microelectronics control and power supply and heating element(s) are safely contained within the valve capsule such that they do not present any danger to the patient.
- Having received the confirmation signal, the patient may now leave the doctor's office and return home. The patient tracks the passage of the intragastric balloon and informs the doctor when it has passed.
Claims (17)
1. An inflatable intragastric balloon useful for facilitating weight loss in a patient in need thereof and suitable for remote deflation comprising:
a shell for containing a volume of fluid introduced therein;
a valve for adjusting the volume of fluid in said shell;
a remotely-activated deflation mechanism for emptying the volume of fluid in said shell; and
a remote control for communicating with said remotely-activated deflation mechanism from outside the patient's body.
2. The intragastric balloon of claim 1 , wherein said remotely-activated deflation mechanism comprises a meltable sealing plug.
3. The intragastric balloon of claim 1 , wherein said remotely-activated deflation mechanism comprises a shape memory element, wherein application of heat to said shape memory element causes said shape memory element to deform.
4. The intragastric balloon of claim 1 further comprising a quick fill valve.
5. The intragastric balloon of claim 1 , wherein said shell comprises at least one of the following materials: diphenyl silicone, PTFE, silicone-polyurethane elastomer, HDPE, LDPE, or parylene coating.
6. The intragastric balloon of claim 3 , wherein said shape memory element comprises a shape memory alloy.
7. The intragastric balloon of claim 6 , wherein said shape memory element comprises NiTiNOL.
8. The intragastric balloon of claim 3 , wherein said shape memory element comprises a shape memory polymer.
9. The intragastric balloon of claim 1 , wherein said remotely-activated deflation mechanism further comprises a battery for powering said remote deflation mechanism.
10. The intragastric balloon of claim 1 , wherein said remotely-activated deflation mechanism further comprises microelectronics for controlling said remote deflation mechanism.
11. The intragastric balloon of claim 1 , wherein said remotely-activated deflation mechanism is powered by induction from outside the patient's body.
12. The intragastric balloon of claim 3 , wherein said shape memory element comprises a cutting wire, wherein application of heat to said shape memory element causes said cutting wire to deform, thereby forming an opening in said shell.
13. The intragastric balloon of claim 10 , wherein said shape memory element further comprises a plug proximate said cutting wire, wherein upon application of heat, said cutting wire deforms to open said plug.
14. The intragastric balloon of claim 3 , wherein said shape memory element comprises a spring and a plug detachably mounted thereto, wherein upon application of heat said spring deforms to open said plug.
15. The intragastric balloon of claim 3 , wherein said shape memory element comprises an actuator, and said remotely-activated deflation mechanism comprises a spring collar and an obstruction for holding said spring collar in a first position, and a slit valve, wherein upon application of heat said actuator deforms to eject said obstruction, thereby causing said spring collar to move to a second position in which said slit valve opens.
16. The intragastric balloon of claim 1 , wherein the valve is in a self-contained capsule that may be ejected by a remotely-activated deflation mechanism.
17. A method for the in vivo remote deflation and removal from a mammalian body of an intragastric balloon containing a volume of fluid therein comprising the steps of:
remotely activating a deflation mechanism to create an opening in the shell;
allowing normal intragastric movements to drain fluid from the balloon; and
allowing the deflated balloon to pass through the body.
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/735,194 US20080255601A1 (en) | 2007-04-13 | 2007-04-13 | Apparatus and method for remote deflation of intragastric balloon |
AT08745382T ATE522191T1 (en) | 2007-04-13 | 2008-04-09 | REMOTE-CONTROLLED DEFLATION OF A STOMACH BALLOON |
KR1020097023350A KR20100016353A (en) | 2007-04-13 | 2008-04-09 | Remote deflation of intragastric balloon |
MX2009011021A MX2009011021A (en) | 2007-04-13 | 2008-04-09 | Remote deflation of intragastric balloon. |
BRPI0810639A BRPI0810639A2 (en) | 2007-04-13 | 2008-04-09 | "apparatus and method for remote emptying of intragastric balloon". |
CA2683715A CA2683715C (en) | 2007-04-13 | 2008-04-09 | Apparatus and method for remote deflation of intragastric balloon |
JP2010503182A JP2010523280A (en) | 2007-04-13 | 2008-04-09 | Remote contraction of intragastric balloon |
ES08745382T ES2370929T3 (en) | 2007-04-13 | 2008-04-09 | REMOVED INTRAGASTRIC BALL REMOVAL. |
CN200880019831A CN101677868A (en) | 2007-04-13 | 2008-04-09 | Remote deflation of intragastric balloon |
PCT/US2008/059766 WO2008127941A2 (en) | 2007-04-13 | 2008-04-09 | Remote deflation of intragastric balloon |
EP08745382A EP2139439B1 (en) | 2007-04-13 | 2008-04-09 | Remote deflation of intragastric balloon |
AU2008239896A AU2008239896A1 (en) | 2007-04-13 | 2008-04-09 | Remote deflation of intragastric balloon |
US12/698,906 US9173757B2 (en) | 2007-04-13 | 2010-02-02 | Apparatus and method for remote deflation of intragastric balloon |
HK10104435.3A HK1136482A1 (en) | 2007-04-13 | 2010-05-06 | Remote deflation of intragastric balloon |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/735,194 US20080255601A1 (en) | 2007-04-13 | 2007-04-13 | Apparatus and method for remote deflation of intragastric balloon |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/698,906 Continuation-In-Part US9173757B2 (en) | 2007-04-13 | 2010-02-02 | Apparatus and method for remote deflation of intragastric balloon |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080255601A1 true US20080255601A1 (en) | 2008-10-16 |
Family
ID=39523333
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/735,194 Abandoned US20080255601A1 (en) | 2007-04-13 | 2007-04-13 | Apparatus and method for remote deflation of intragastric balloon |
US12/698,906 Active 2028-04-06 US9173757B2 (en) | 2007-04-13 | 2010-02-02 | Apparatus and method for remote deflation of intragastric balloon |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/698,906 Active 2028-04-06 US9173757B2 (en) | 2007-04-13 | 2010-02-02 | Apparatus and method for remote deflation of intragastric balloon |
Country Status (13)
Country | Link |
---|---|
US (2) | US20080255601A1 (en) |
EP (1) | EP2139439B1 (en) |
JP (1) | JP2010523280A (en) |
KR (1) | KR20100016353A (en) |
CN (1) | CN101677868A (en) |
AT (1) | ATE522191T1 (en) |
AU (1) | AU2008239896A1 (en) |
BR (1) | BRPI0810639A2 (en) |
CA (1) | CA2683715C (en) |
ES (1) | ES2370929T3 (en) |
HK (1) | HK1136482A1 (en) |
MX (1) | MX2009011021A (en) |
WO (1) | WO2008127941A2 (en) |
Cited By (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070100368A1 (en) * | 2005-10-31 | 2007-05-03 | Quijano Rodolfo C | Intragastric space filler |
US20070288033A1 (en) * | 2006-06-09 | 2007-12-13 | Allergan, Inc. | Intragastric balloon retrieval mechanisms |
US20080172079A1 (en) * | 2006-09-29 | 2008-07-17 | Allergan, Inc. | Apparatus and method for intragastric balloon with in situ adjustment means |
US20080243071A1 (en) * | 2007-03-30 | 2008-10-02 | Quijano Rodolfo C | Intragastric balloon system and therapeutic processes and products |
US20100130998A1 (en) * | 2002-05-09 | 2010-05-27 | Alverdy John C | Balloon System and Methods for Treating Obesity |
WO2011038270A3 (en) * | 2009-09-24 | 2011-10-06 | Reshape Medical, Inc. | Normalization and stabilization of balloon surfaces for deflation |
WO2012158972A2 (en) * | 2011-05-17 | 2012-11-22 | Endobese, Inc. | Method and apparatus for buoyant gastric implant |
US20130289604A1 (en) * | 2011-01-21 | 2013-10-31 | Obalon Therapeutics, Inc | Intragastric device |
US8683881B2 (en) | 2009-04-03 | 2014-04-01 | Reshape Medical, Inc. | Intragastric space fillers and methods of manufacturing including in vitro testing |
US8864840B2 (en) | 2010-10-19 | 2014-10-21 | Apollo Endosurgery, Inc. | Intragastric implants with collapsible frames |
US8870966B2 (en) | 2010-10-18 | 2014-10-28 | Apollo Endosurgery, Inc. | Intragastric balloon for treating obesity |
US8888732B2 (en) | 2011-03-11 | 2014-11-18 | Apollo Endosurgery, Inc. | Intraluminal sleeve with active agents |
US8920447B2 (en) | 2010-10-19 | 2014-12-30 | Apollo Endosurgery, Inc. | Articulated gastric implant clip |
US8956380B2 (en) | 2010-10-18 | 2015-02-17 | Apollo Endosurgery, Inc. | Reactive intragastric implant devices |
US9050174B2 (en) | 2009-07-23 | 2015-06-09 | Reshape Medical, Inc. | Deflation and removal of implantable medical devices |
US9149611B2 (en) | 2010-02-08 | 2015-10-06 | Reshape Medical, Inc. | Materials and methods for improved intragastric balloon devices |
US9173757B2 (en) | 2007-04-13 | 2015-11-03 | Apollo Endosurgery, Inc. | Apparatus and method for remote deflation of intragastric balloon |
US9174031B2 (en) | 2009-03-13 | 2015-11-03 | Reshape Medical, Inc. | Device and method for deflation and removal of implantable and inflatable devices |
US9192501B2 (en) | 2010-04-30 | 2015-11-24 | Apollo Endosurgery, Inc. | Remotely powered remotely adjustable gastric band system |
US9198790B2 (en) | 2010-10-19 | 2015-12-01 | Apollo Endosurgery, Inc. | Upper stomach gastric implants |
US9283102B2 (en) | 2007-06-25 | 2016-03-15 | Reshape Medical, Inc. | Gastric space filler device, delivery system, and related methods |
US9358143B2 (en) | 2009-07-22 | 2016-06-07 | Reshape Medical, Inc. | Retrieval mechanisms for implantable medical devices |
US9398969B2 (en) | 2010-10-19 | 2016-07-26 | Apollo Endosurgery, Inc. | Upper stomach gastric implants |
US9463107B2 (en) | 2010-10-18 | 2016-10-11 | Apollo Endosurgery, Inc. | Variable size intragastric implant devices |
US9498365B2 (en) | 2010-10-19 | 2016-11-22 | Apollo Endosurgery, Inc. | Intragastric implants with multiple fluid chambers |
US9604038B2 (en) | 2009-07-23 | 2017-03-28 | Reshape Medical, Inc. | Inflation and deflation mechanisms for inflatable medical devices |
US9622896B2 (en) | 2010-02-08 | 2017-04-18 | Reshape Medical, Inc. | Enhanced aspiration processes and mechanisms for instragastric devices |
US9629740B2 (en) | 2010-04-06 | 2017-04-25 | Reshape Medical, Inc. | Inflation devices for intragastric devices with improved attachment and detachment and associated systems and methods |
US9668901B2 (en) | 2010-10-18 | 2017-06-06 | Apollo Endosurgery Us, Inc. | Intragastric implants with duodenal anchors |
US9681973B2 (en) | 2010-02-25 | 2017-06-20 | Reshape Medical, Inc. | Enhanced explant processes and mechanisms for intragastric devices |
US9895248B2 (en) | 2014-10-09 | 2018-02-20 | Obalon Therapeutics, Inc. | Ultrasonic systems and methods for locating and/or characterizing intragastric devices |
US10070980B2 (en) | 2010-10-19 | 2018-09-11 | Apollo Endosurgery Us, Inc. | Anchored non-piercing duodenal sleeve and delivery systems |
US20180346330A1 (en) * | 2015-11-24 | 2018-12-06 | Ge Aviation Systems Limited | Solid state delivery system |
US10264995B2 (en) | 2013-12-04 | 2019-04-23 | Obalon Therapeutics, Inc. | Systems and methods for locating and/or characterizing intragastric devices |
US10335303B2 (en) | 2015-12-07 | 2019-07-02 | Obalon Therapeutics, Inc. | Intragastric device |
US10350100B2 (en) | 2016-04-12 | 2019-07-16 | Obalon Therapeutics, Inc. | System for detecting an intragastric balloon |
US10537453B2 (en) | 2015-12-16 | 2020-01-21 | Obalon Therapeutics, Inc. | Intragastric device with expandable portions |
US10874537B2 (en) | 2008-10-16 | 2020-12-29 | Obalon Therapeutics, Inc. | Intragastric volume-occupying device and method for fabricating same |
US11819433B2 (en) | 2016-11-04 | 2023-11-21 | Reshape Lifesciences Inc. | Pressure control system for intragastric device |
US20240050254A1 (en) * | 2019-09-20 | 2024-02-15 | Leonardo Salles De Almeida | Devices and method for bi-directional adjustment of intragastric balloons, and shut-off valve |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100114311A1 (en) * | 2008-11-05 | 2010-05-06 | Hilton Becker | Multi-Lumen Breast Prothesis and Improved Valve Assembly Therefor |
KR101877776B1 (en) * | 2011-08-09 | 2018-07-12 | 엘지디스플레이 주식회사 | Driving integrated circuit for backlight driver and liquid crystal display device including the same |
US9849018B2 (en) | 2012-02-21 | 2017-12-26 | Allurion Technologies, Inc. | Ingestible delivery systems and methods |
US8974483B2 (en) | 2012-02-21 | 2015-03-10 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
US10182932B2 (en) | 2012-02-21 | 2019-01-22 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
CA2865056C (en) | 2012-02-21 | 2021-07-20 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
AU2014342014B2 (en) * | 2013-11-01 | 2019-02-14 | Allurion Technologies, Llc | Methods and devices for deploying and releasing a temporary implant within the body |
BR112017024064B1 (en) * | 2015-06-11 | 2022-09-27 | Obalon Therapeutics, Inc | DISPENSER AND INTRAGASTRIC BALLOON SYSTEM |
CN110461408B (en) * | 2017-02-09 | 2022-01-21 | 斯帕茨菲亚有限公司 | Check valve with docking station for gastrointestinal balloon |
WO2019165449A1 (en) | 2018-02-26 | 2019-08-29 | Allurion Technologies, Inc. | Automatic-sealing balloon-filling catheter system |
ES2974220T3 (en) | 2018-07-06 | 2024-06-26 | Allurion Tech Inc | Binary Fluid Control Valve System |
WO2020123916A1 (en) | 2018-12-13 | 2020-06-18 | Allurion Technologies, Inc. | Enhanced fluid delivery system |
CN111345927A (en) * | 2018-12-20 | 2020-06-30 | 上海微创医疗器械(集团)有限公司 | Sacculus, sacculus connection structure and sacculus device |
JP7266505B2 (en) * | 2019-10-15 | 2023-04-28 | 英敏 太田 | Gastric space filling device and method of operation thereof |
Citations (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1702974A (en) * | 1928-05-12 | 1929-02-19 | Spalding & Bros Ag | Collapsible valve and method of making same |
US3919724A (en) * | 1974-06-07 | 1975-11-18 | Medical Eng Corp | Implantable prosthesis having a self-sealing valve |
US4430392A (en) * | 1983-02-11 | 1984-02-07 | Honeywell Inc. | Heat activated vent |
US4485805A (en) * | 1982-08-24 | 1984-12-04 | Gunther Pacific Limited Of Hong Kong | Weight loss device and method |
US4607618A (en) * | 1983-02-23 | 1986-08-26 | Angelchik Jean P | Method for treatment of morbid obesity |
US4636213A (en) * | 1985-01-24 | 1987-01-13 | Pakiam Anthony I | Implantable prosthesis |
US4694827A (en) * | 1986-01-14 | 1987-09-22 | Weiner Brian C | Inflatable gastric device for treating obesity and method of using the same |
US4930535A (en) * | 1987-05-14 | 1990-06-05 | Mcghan Medical Corporation | Folding leaf valve and method of making |
US4969899A (en) * | 1989-03-08 | 1990-11-13 | Cox-Uphoff International | Inflatable implant |
US5084061A (en) * | 1987-09-25 | 1992-01-28 | Gau Fred C | Intragastric balloon with improved valve locating means |
US5211371A (en) * | 1991-07-22 | 1993-05-18 | Advanced Control Technologies, Inc. | Linearly actuated valve |
US5725507A (en) * | 1994-03-04 | 1998-03-10 | Mentor Corporation | Self-sealing injection sites and plugs |
US5819749A (en) * | 1995-09-25 | 1998-10-13 | Regents Of The University Of California | Microvalve |
US6102897A (en) * | 1996-11-19 | 2000-08-15 | Lang; Volker | Microvalve |
US6454785B2 (en) * | 2000-02-24 | 2002-09-24 | DE HOYOS GARZA ANDRéS | Percutaneous intragastric balloon catheter for the treatment of obesity |
US20030106761A1 (en) * | 2001-12-07 | 2003-06-12 | Taylor William Morris | Shape memory alloy wrap spring clutch |
US6579301B1 (en) * | 2000-11-17 | 2003-06-17 | Syntheon, Llc | Intragastric balloon device adapted to be repeatedly varied in volume without external assistance |
US6629776B2 (en) * | 2000-12-12 | 2003-10-07 | Mini-Mitter Company, Inc. | Digital sensor for miniature medical thermometer, and body temperature monitor |
US6733513B2 (en) * | 1999-11-04 | 2004-05-11 | Advanced Bioprosthetic Surfaces, Ltd. | Balloon catheter having metal balloon and method of making same |
US6733512B2 (en) * | 2002-03-07 | 2004-05-11 | Mcghan Jim J. | Self-deflating intragastric balloon |
US6746460B2 (en) * | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
US20050055039A1 (en) * | 2003-07-28 | 2005-03-10 | Polymorfix, Inc. | Devices and methods for pyloric anchoring |
US20050190070A1 (en) * | 2001-03-07 | 2005-09-01 | Telezygology Inc. | Closure with concertina element and processing means |
US20050192615A1 (en) * | 2000-11-03 | 2005-09-01 | Torre Roger D.L. | Method and device for use in minimally invasive placement of intragastric devices |
US20050240279A1 (en) * | 2002-11-01 | 2005-10-27 | Jonathan Kagan | Gastrointestinal sleeve device and methods for treatment of morbid obesity |
US20050250979A1 (en) * | 2002-08-13 | 2005-11-10 | Coe Frederick L | Remotely adjustable gastric banding device and method |
US20050267595A1 (en) * | 2004-05-03 | 2005-12-01 | Fulfillium, Inc., A Delaware Corporation | Methods for gastric volume control |
US7020531B1 (en) * | 2001-05-01 | 2006-03-28 | Intrapace, Inc. | Gastric device and suction assisted method for implanting a device on a stomach wall |
US20060069403A1 (en) * | 2004-09-21 | 2006-03-30 | Shalon Ventures, Inc. | Tissue expansion devices |
US7056305B2 (en) * | 2001-03-09 | 2006-06-06 | Garza Alvarez Jose Rafael | Intragastric balloon assembly |
US20060142700A1 (en) * | 2003-06-20 | 2006-06-29 | Sobelman Owen S | Two-way slit valve |
US20070016262A1 (en) * | 2005-07-13 | 2007-01-18 | Betastim, Ltd. | Gi and pancreatic device for treating obesity and diabetes |
US20070083224A1 (en) * | 2005-06-16 | 2007-04-12 | Hively Robert L | Gastric bariatric apparatus with selective inflation and safety features |
US7214233B2 (en) * | 2002-08-30 | 2007-05-08 | Satiety, Inc. | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach |
US20070156248A1 (en) * | 2005-03-01 | 2007-07-05 | Doron Marco | Bioerodible self-deployable intragastric implants |
Family Cites Families (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2163048A (en) * | 1937-02-13 | 1939-06-20 | Mckee Brothers Corp | Band clamp |
BE758322A (en) * | 1969-11-03 | 1971-04-01 | Bosch Gmbh Robert | DEVICE FOR WIPING GLASSES SUCH AS HEADLIGHT GLASS AND REAR LAMP OF MOTOR VEHICLES |
US3719973A (en) * | 1972-03-03 | 1973-03-13 | Might Mac Inc | T-bar zipper tab handle |
US3840018A (en) * | 1973-01-31 | 1974-10-08 | M Heifetz | Clamp for occluding tubular conduits in the human body |
US4118805A (en) * | 1977-02-28 | 1978-10-10 | Codman & Shurtleff, Inc. | Artificial sphincter |
GB2086792B (en) | 1980-11-07 | 1984-12-12 | Microsurgical Administrative S | Gripping devices |
US4545367A (en) * | 1982-07-16 | 1985-10-08 | Cordis Corporation | Detachable balloon catheter and method of use |
IL67773A (en) * | 1983-01-28 | 1985-02-28 | Antebi E | Tie for tying live tissue and an instrument for performing said tying operation |
US4881939A (en) * | 1985-02-19 | 1989-11-21 | The Johns Hopkins University | Implantable helical cuff |
US4723547A (en) * | 1985-05-07 | 1988-02-09 | C. R. Bard, Inc. | Anti-obesity balloon placement system |
US4598699A (en) * | 1985-06-10 | 1986-07-08 | Garren Lloyd R | Endoscopic instrument for removing stomach insert |
JPS63264078A (en) | 1987-04-22 | 1988-10-31 | オリンパス光学工業株式会社 | Balloon for diet |
JPS63279854A (en) | 1987-05-12 | 1988-11-16 | Olympus Optical Co Ltd | Diet balloon extracting apparatus |
DE8804765U1 (en) | 1988-04-12 | 1989-05-11 | Witzel, Lothar, Prof. Dr., 1000 Berlin | Gastric balloon for weight loss |
US5527340A (en) * | 1990-04-20 | 1996-06-18 | S & T Marketing Ag | Surgical instrument with gripping portion |
US5074868A (en) * | 1990-08-03 | 1991-12-24 | Inamed Development Company | Reversible stoma-adjustable gastric band |
US5226429A (en) * | 1991-06-20 | 1993-07-13 | Inamed Development Co. | Laparoscopic gastric band and method |
US5289817A (en) * | 1991-08-20 | 1994-03-01 | Linvatec Corporation | Endoscopic surgical retractor |
US5972000A (en) | 1992-11-13 | 1999-10-26 | Influence Medical Technologies, Ltd. | Non-linear anchor inserter device and bone anchors |
US5449368A (en) * | 1993-02-18 | 1995-09-12 | Kuzmak; Lubomyr I. | Laparoscopic adjustable gastric banding device and method for implantation and removal thereof |
US5601604A (en) * | 1993-05-27 | 1997-02-11 | Inamed Development Co. | Universal gastric band |
WO1995005860A1 (en) * | 1993-08-23 | 1995-03-02 | Boston Scientific Corporation | Improved balloon catheter |
US5658298A (en) * | 1993-11-09 | 1997-08-19 | Inamed Development Company | Laparoscopic tool |
JP3707822B2 (en) * | 1995-03-23 | 2005-10-19 | 富士写真フイルム株式会社 | Image display device |
US6102922A (en) * | 1995-09-22 | 2000-08-15 | Kirk Promotions Limited | Surgical method and device for reducing the food intake of patient |
US5997517A (en) | 1997-01-27 | 1999-12-07 | Sts Biopolymers, Inc. | Bonding layers for medical device surface coatings |
ATE246771T1 (en) * | 1997-04-04 | 2003-08-15 | Christian Peclat | PERISTALTIC PUMP |
US5938669A (en) * | 1997-05-07 | 1999-08-17 | Klasamed S.A. | Adjustable gastric banding device for contracting a patient's stomach |
US6074341A (en) * | 1998-06-09 | 2000-06-13 | Timm Medical Technologies, Inc. | Vessel occlusive apparatus and method |
JP3426510B2 (en) * | 1998-07-27 | 2003-07-14 | ペンタックス株式会社 | High frequency snare for endoscope |
FR2783153B1 (en) * | 1998-09-14 | 2000-12-01 | Jerome Dargent | GASTRIC CONSTRICTION DEVICE |
US6290575B1 (en) * | 1999-03-01 | 2001-09-18 | John I. Shipp | Surgical ligation clip with increased ligating force |
FR2797181B1 (en) | 1999-08-05 | 2002-05-03 | Richard Cancel | REMOTE GASTRIC BAND DEVICE FOR FORMING A RESTRICTED STOMA OPENING IN THE ESTOMAC |
US6454699B1 (en) * | 2000-02-11 | 2002-09-24 | Obtech Medical Ag | Food intake restriction with controlled wireless energy supply |
US6464628B1 (en) * | 1999-08-12 | 2002-10-15 | Obtech Medical Ag | Mechanical anal incontinence |
US6371971B1 (en) * | 1999-11-15 | 2002-04-16 | Scimed Life Systems, Inc. | Guidewire filter and methods of use |
US6470892B1 (en) * | 2000-02-10 | 2002-10-29 | Obtech Medical Ag | Mechanical heartburn and reflux treatment |
US6503264B1 (en) | 2000-03-03 | 2003-01-07 | Bioenterics Corporation | Endoscopic device for removing an intragastric balloon |
US6513403B2 (en) | 2001-04-03 | 2003-02-04 | Cray Inc. | Flexible drive rod for access to enclosed locations |
FR2823663B1 (en) | 2001-04-18 | 2004-01-02 | Cousin Biotech | DEVICE FOR TREATING MORBID OBESITY |
WO2002090807A1 (en) * | 2001-05-08 | 2002-11-14 | Scuola Superiore Di Studi Universitari E Di Perfezionamento S. Anna | Proportional valve with shape memory alloy (sma) actuator |
US6511490B2 (en) * | 2001-06-22 | 2003-01-28 | Antoine Jean Henri Robert | Gastric banding device and method |
US6659937B2 (en) | 2001-10-11 | 2003-12-09 | M. Sheldon Polsky | Continent bladder access device |
FR2834198B1 (en) | 2001-12-28 | 2004-10-15 | Cie Euro Etude Rech Paroscopie | MEDICAL EXPLANTATION DEVICE |
FR2840804B1 (en) | 2002-06-13 | 2004-09-17 | Richard Cancel | SYSTEM FOR THE TREATMENT OF OBESITY AND IMPLANT FOR SUCH A SYSTEM |
DE60331457D1 (en) | 2002-08-28 | 2010-04-08 | Allergan Inc | TEMPTING MAGNETIC BANDING DEVICE |
ES2291405T3 (en) | 2002-09-04 | 2008-03-01 | Endoart S.A. | SURGICAL RING PROVIDED WITH A REMOTE CONTROL SYSTEM AND REVERSIBLE IN THE VARIATION OF YOUR DIAMETER. |
DE60223535T2 (en) | 2002-09-04 | 2008-09-18 | Endoart S.A. | Device for closing surgical rings |
US7613515B2 (en) | 2003-02-03 | 2009-11-03 | Enteromedics Inc. | High frequency vagal blockage therapy |
FR2852821B1 (en) | 2003-03-31 | 2007-06-01 | Cie Euro Etude Rech Paroscopie | PARYLENE-COATED INTRA-GASTRIC BALLOON, PROCESS FOR PRODUCING SUCH BALLOON AND USE OF PARYLENE FOR COATING INTRA-GASTRIC BALLOON |
FR2855744B1 (en) | 2003-06-04 | 2006-04-14 | Cie Euro Etude Rech Paroscopie | SURGICAL RING WITH IMPROVED CLOSURE SYSTEM |
US6994095B2 (en) * | 2003-07-28 | 2006-02-07 | Medventure Associates Iv | Pyloric valve corking device and method |
US20090259236A2 (en) | 2003-07-28 | 2009-10-15 | Baronova, Inc. | Gastric retaining devices and methods |
US8236023B2 (en) | 2004-03-18 | 2012-08-07 | Allergan, Inc. | Apparatus and method for volume adjustment of intragastric balloons |
US20050261711A1 (en) | 2004-05-24 | 2005-11-24 | Olympus Corporation | Treatment method and endoscope apparatus |
US20060025799A1 (en) | 2004-07-27 | 2006-02-02 | Patrick Basu | Endoscopically placed gastric balloon (EPGB) device and method for treating obesity involving the same |
US20070078476A1 (en) | 2004-10-12 | 2007-04-05 | Hull Wendell C Sr | Overweight control apparatuses for insertion into the stomach |
WO2006063593A2 (en) | 2004-12-14 | 2006-06-22 | Rune Wessel Weltlesen | A system and a method for treating of obesity by use of an intragastric balloon |
US20080269555A1 (en) | 2005-02-24 | 2008-10-30 | Compagnie Europeenne D'etude Et De Recherche De Di Spositifs Pour L'lmplantation Par Laparoscopie | Intragastric Balloon With Extraction Reinforcement |
US7736385B2 (en) | 2005-03-24 | 2010-06-15 | Cook Incorporated | Exchangeable delivery system with distal protection |
US9345604B2 (en) | 2005-05-02 | 2016-05-24 | Almuhannad Alfrhan | Percutaneous intragastric balloon device and method |
WO2007011086A1 (en) | 2005-07-19 | 2007-01-25 | Hyvix Co., Ltd. | Method and apparatus for converting gradation data in lcd |
CA2618371A1 (en) | 2005-08-11 | 2007-02-15 | Adrian Paz | Implantable device for obesity prevention |
US8936590B2 (en) * | 2005-11-09 | 2015-01-20 | The Invention Science Fund I, Llc | Acoustically controlled reaction device |
US8152710B2 (en) | 2006-04-06 | 2012-04-10 | Ethicon Endo-Surgery, Inc. | Physiological parameter analysis for an implantable restriction device and a data logger |
US20070288033A1 (en) | 2006-06-09 | 2007-12-13 | Allergan, Inc. | Intragastric balloon retrieval mechanisms |
US9326877B2 (en) | 2006-09-29 | 2016-05-03 | Apollo Endosurgery, Inc. | Apparatus and method for intragastric balloon with in situ adjustment means |
US8226602B2 (en) | 2007-03-30 | 2012-07-24 | Reshape Medical, Inc. | Intragastric balloon system and therapeutic processes and products |
US20080255601A1 (en) | 2007-04-13 | 2008-10-16 | Allergan, Inc. | Apparatus and method for remote deflation of intragastric balloon |
DE102007025312A1 (en) | 2007-05-25 | 2008-11-27 | Q Medical International Ag | Intragastric stomach use for the treatment of obesity |
WO2009055386A2 (en) | 2007-10-23 | 2009-04-30 | Allergan, Inc. | Pressure sensing intragastric balloon |
CA3109478A1 (en) | 2008-01-29 | 2009-08-06 | Implantica Patent Ltd. | Implantable movement restriction device for stomach fundas wall invagination |
US20090259246A1 (en) * | 2008-04-14 | 2009-10-15 | Sherif Eskaros | Intragastric Volume-Occupying Device |
US8317677B2 (en) * | 2008-10-06 | 2012-11-27 | Allergan, Inc. | Mechanical gastric band with cushions |
US9364362B2 (en) * | 2008-10-21 | 2016-06-14 | General Electric Company | Implantable device system |
FR2941617B1 (en) | 2009-02-04 | 2012-06-29 | Endalis | INTRA-GASTRIC BALLOON. |
-
2007
- 2007-04-13 US US11/735,194 patent/US20080255601A1/en not_active Abandoned
-
2008
- 2008-04-09 KR KR1020097023350A patent/KR20100016353A/en not_active Application Discontinuation
- 2008-04-09 WO PCT/US2008/059766 patent/WO2008127941A2/en active Application Filing
- 2008-04-09 AT AT08745382T patent/ATE522191T1/en not_active IP Right Cessation
- 2008-04-09 ES ES08745382T patent/ES2370929T3/en active Active
- 2008-04-09 CN CN200880019831A patent/CN101677868A/en active Pending
- 2008-04-09 EP EP08745382A patent/EP2139439B1/en active Active
- 2008-04-09 MX MX2009011021A patent/MX2009011021A/en not_active Application Discontinuation
- 2008-04-09 CA CA2683715A patent/CA2683715C/en active Active
- 2008-04-09 BR BRPI0810639A patent/BRPI0810639A2/en not_active IP Right Cessation
- 2008-04-09 JP JP2010503182A patent/JP2010523280A/en active Pending
- 2008-04-09 AU AU2008239896A patent/AU2008239896A1/en not_active Abandoned
-
2010
- 2010-02-02 US US12/698,906 patent/US9173757B2/en active Active
- 2010-05-06 HK HK10104435.3A patent/HK1136482A1/en not_active IP Right Cessation
Patent Citations (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1702974A (en) * | 1928-05-12 | 1929-02-19 | Spalding & Bros Ag | Collapsible valve and method of making same |
US3919724A (en) * | 1974-06-07 | 1975-11-18 | Medical Eng Corp | Implantable prosthesis having a self-sealing valve |
US4485805A (en) * | 1982-08-24 | 1984-12-04 | Gunther Pacific Limited Of Hong Kong | Weight loss device and method |
US4430392A (en) * | 1983-02-11 | 1984-02-07 | Honeywell Inc. | Heat activated vent |
US4607618A (en) * | 1983-02-23 | 1986-08-26 | Angelchik Jean P | Method for treatment of morbid obesity |
US4636213A (en) * | 1985-01-24 | 1987-01-13 | Pakiam Anthony I | Implantable prosthesis |
US4694827A (en) * | 1986-01-14 | 1987-09-22 | Weiner Brian C | Inflatable gastric device for treating obesity and method of using the same |
US4930535A (en) * | 1987-05-14 | 1990-06-05 | Mcghan Medical Corporation | Folding leaf valve and method of making |
US5084061A (en) * | 1987-09-25 | 1992-01-28 | Gau Fred C | Intragastric balloon with improved valve locating means |
US4969899A (en) * | 1989-03-08 | 1990-11-13 | Cox-Uphoff International | Inflatable implant |
US5211371A (en) * | 1991-07-22 | 1993-05-18 | Advanced Control Technologies, Inc. | Linearly actuated valve |
US5725507A (en) * | 1994-03-04 | 1998-03-10 | Mentor Corporation | Self-sealing injection sites and plugs |
US5819749A (en) * | 1995-09-25 | 1998-10-13 | Regents Of The University Of California | Microvalve |
US6102897A (en) * | 1996-11-19 | 2000-08-15 | Lang; Volker | Microvalve |
US6733513B2 (en) * | 1999-11-04 | 2004-05-11 | Advanced Bioprosthetic Surfaces, Ltd. | Balloon catheter having metal balloon and method of making same |
US6454785B2 (en) * | 2000-02-24 | 2002-09-24 | DE HOYOS GARZA ANDRéS | Percutaneous intragastric balloon catheter for the treatment of obesity |
US20050192615A1 (en) * | 2000-11-03 | 2005-09-01 | Torre Roger D.L. | Method and device for use in minimally invasive placement of intragastric devices |
US6579301B1 (en) * | 2000-11-17 | 2003-06-17 | Syntheon, Llc | Intragastric balloon device adapted to be repeatedly varied in volume without external assistance |
US6629776B2 (en) * | 2000-12-12 | 2003-10-07 | Mini-Mitter Company, Inc. | Digital sensor for miniature medical thermometer, and body temperature monitor |
US20050190070A1 (en) * | 2001-03-07 | 2005-09-01 | Telezygology Inc. | Closure with concertina element and processing means |
US7056305B2 (en) * | 2001-03-09 | 2006-06-06 | Garza Alvarez Jose Rafael | Intragastric balloon assembly |
US7020531B1 (en) * | 2001-05-01 | 2006-03-28 | Intrapace, Inc. | Gastric device and suction assisted method for implanting a device on a stomach wall |
US20030106761A1 (en) * | 2001-12-07 | 2003-06-12 | Taylor William Morris | Shape memory alloy wrap spring clutch |
US6733512B2 (en) * | 2002-03-07 | 2004-05-11 | Mcghan Jim J. | Self-deflating intragastric balloon |
US6746460B2 (en) * | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
US20050250979A1 (en) * | 2002-08-13 | 2005-11-10 | Coe Frederick L | Remotely adjustable gastric banding device and method |
US7214233B2 (en) * | 2002-08-30 | 2007-05-08 | Satiety, Inc. | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach |
US20050240279A1 (en) * | 2002-11-01 | 2005-10-27 | Jonathan Kagan | Gastrointestinal sleeve device and methods for treatment of morbid obesity |
US7037344B2 (en) * | 2002-11-01 | 2006-05-02 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
US20060142700A1 (en) * | 2003-06-20 | 2006-06-29 | Sobelman Owen S | Two-way slit valve |
US20050055039A1 (en) * | 2003-07-28 | 2005-03-10 | Polymorfix, Inc. | Devices and methods for pyloric anchoring |
US20050267595A1 (en) * | 2004-05-03 | 2005-12-01 | Fulfillium, Inc., A Delaware Corporation | Methods for gastric volume control |
US20050267596A1 (en) * | 2004-05-03 | 2005-12-01 | Fulfillium, Inc. A Delaware Corporation | Devices and systems for gastric volume control |
US20060069403A1 (en) * | 2004-09-21 | 2006-03-30 | Shalon Ventures, Inc. | Tissue expansion devices |
US20070156248A1 (en) * | 2005-03-01 | 2007-07-05 | Doron Marco | Bioerodible self-deployable intragastric implants |
US20070083224A1 (en) * | 2005-06-16 | 2007-04-12 | Hively Robert L | Gastric bariatric apparatus with selective inflation and safety features |
US20070016262A1 (en) * | 2005-07-13 | 2007-01-18 | Betastim, Ltd. | Gi and pancreatic device for treating obesity and diabetes |
Cited By (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8845672B2 (en) | 2002-05-09 | 2014-09-30 | Reshape Medical, Inc. | Balloon system and methods for treating obesity |
US20100130998A1 (en) * | 2002-05-09 | 2010-05-27 | Alverdy John C | Balloon System and Methods for Treating Obesity |
US9668900B2 (en) | 2002-05-09 | 2017-06-06 | Reshape Medical, Inc. | Balloon system and methods for treating obesity |
US20070100368A1 (en) * | 2005-10-31 | 2007-05-03 | Quijano Rodolfo C | Intragastric space filler |
US9125726B2 (en) | 2006-06-09 | 2015-09-08 | Apollo Endosurgery, Inc. | Intragastric balloon retrieval mechanisms |
US20070288033A1 (en) * | 2006-06-09 | 2007-12-13 | Allergan, Inc. | Intragastric balloon retrieval mechanisms |
US20100168783A1 (en) * | 2006-06-09 | 2010-07-01 | Allergan, Inc. | Intragastric balloon retrieval mechanisms |
US8753369B2 (en) | 2006-06-09 | 2014-06-17 | Apollo Endosurgery, Inc. | Intragastric balloon retrieval mechanisms |
US20080172079A1 (en) * | 2006-09-29 | 2008-07-17 | Allergan, Inc. | Apparatus and method for intragastric balloon with in situ adjustment means |
US9326877B2 (en) | 2006-09-29 | 2016-05-03 | Apollo Endosurgery, Inc. | Apparatus and method for intragastric balloon with in situ adjustment means |
US20080243071A1 (en) * | 2007-03-30 | 2008-10-02 | Quijano Rodolfo C | Intragastric balloon system and therapeutic processes and products |
US8226602B2 (en) | 2007-03-30 | 2012-07-24 | Reshape Medical, Inc. | Intragastric balloon system and therapeutic processes and products |
US9173757B2 (en) | 2007-04-13 | 2015-11-03 | Apollo Endosurgery, Inc. | Apparatus and method for remote deflation of intragastric balloon |
US9283102B2 (en) | 2007-06-25 | 2016-03-15 | Reshape Medical, Inc. | Gastric space filler device, delivery system, and related methods |
US12090075B2 (en) | 2008-10-16 | 2024-09-17 | Reshape Lifesciences Inc. | Intragastric device |
US11219543B2 (en) | 2008-10-16 | 2022-01-11 | Reshape Lifesciences Inc. | Intragastric device |
US12102547B2 (en) | 2008-10-16 | 2024-10-01 | Reshape Lifesciences Inc. | Intragastric volume-occupying device and method for fabricating same |
US10874537B2 (en) | 2008-10-16 | 2020-12-29 | Obalon Therapeutics, Inc. | Intragastric volume-occupying device and method for fabricating same |
US9174031B2 (en) | 2009-03-13 | 2015-11-03 | Reshape Medical, Inc. | Device and method for deflation and removal of implantable and inflatable devices |
US8840952B2 (en) | 2009-04-03 | 2014-09-23 | Reshape Medical, Inc. | Intragastric space fillers and methods of manufacturing including in vitro testing |
US8683881B2 (en) | 2009-04-03 | 2014-04-01 | Reshape Medical, Inc. | Intragastric space fillers and methods of manufacturing including in vitro testing |
US9358143B2 (en) | 2009-07-22 | 2016-06-07 | Reshape Medical, Inc. | Retrieval mechanisms for implantable medical devices |
US9604038B2 (en) | 2009-07-23 | 2017-03-28 | Reshape Medical, Inc. | Inflation and deflation mechanisms for inflatable medical devices |
US9987470B2 (en) | 2009-07-23 | 2018-06-05 | ReShape Medical, LLC | Deflation and removal of implantable medical devices |
US9050174B2 (en) | 2009-07-23 | 2015-06-09 | Reshape Medical, Inc. | Deflation and removal of implantable medical devices |
US8894568B2 (en) | 2009-09-24 | 2014-11-25 | Reshape Medical, Inc. | Normalization and stabilization of balloon surfaces for deflation |
WO2011038270A3 (en) * | 2009-09-24 | 2011-10-06 | Reshape Medical, Inc. | Normalization and stabilization of balloon surfaces for deflation |
US9149611B2 (en) | 2010-02-08 | 2015-10-06 | Reshape Medical, Inc. | Materials and methods for improved intragastric balloon devices |
US9622896B2 (en) | 2010-02-08 | 2017-04-18 | Reshape Medical, Inc. | Enhanced aspiration processes and mechanisms for instragastric devices |
US9579226B2 (en) | 2010-02-08 | 2017-02-28 | Reshape Medical, Inc. | Materials and methods for improved intragastric balloon devices |
US9681973B2 (en) | 2010-02-25 | 2017-06-20 | Reshape Medical, Inc. | Enhanced explant processes and mechanisms for intragastric devices |
US10117766B2 (en) | 2010-04-06 | 2018-11-06 | Reshape Medical Llc | Inflation devices for intragastric devices with improved attachment and detachment and associated systems and methods |
US9629740B2 (en) | 2010-04-06 | 2017-04-25 | Reshape Medical, Inc. | Inflation devices for intragastric devices with improved attachment and detachment and associated systems and methods |
US9192501B2 (en) | 2010-04-30 | 2015-11-24 | Apollo Endosurgery, Inc. | Remotely powered remotely adjustable gastric band system |
US8956380B2 (en) | 2010-10-18 | 2015-02-17 | Apollo Endosurgery, Inc. | Reactive intragastric implant devices |
US9668901B2 (en) | 2010-10-18 | 2017-06-06 | Apollo Endosurgery Us, Inc. | Intragastric implants with duodenal anchors |
US9463107B2 (en) | 2010-10-18 | 2016-10-11 | Apollo Endosurgery, Inc. | Variable size intragastric implant devices |
US9795498B2 (en) | 2010-10-18 | 2017-10-24 | Apollo Endosurgery Us, Inc. | Intragastric balloon for treating obesity |
US8870966B2 (en) | 2010-10-18 | 2014-10-28 | Apollo Endosurgery, Inc. | Intragastric balloon for treating obesity |
US10070980B2 (en) | 2010-10-19 | 2018-09-11 | Apollo Endosurgery Us, Inc. | Anchored non-piercing duodenal sleeve and delivery systems |
US8920447B2 (en) | 2010-10-19 | 2014-12-30 | Apollo Endosurgery, Inc. | Articulated gastric implant clip |
US8864840B2 (en) | 2010-10-19 | 2014-10-21 | Apollo Endosurgery, Inc. | Intragastric implants with collapsible frames |
US9801747B2 (en) | 2010-10-19 | 2017-10-31 | Apollo Endosurgery Us, Inc. | Non-inflatable gastric implants and systems |
US9539133B2 (en) | 2010-10-19 | 2017-01-10 | Apollo Endosurgery, Inc. | Stomach-spanning gastric implants |
US9498365B2 (en) | 2010-10-19 | 2016-11-22 | Apollo Endosurgery, Inc. | Intragastric implants with multiple fluid chambers |
US9681974B2 (en) | 2010-10-19 | 2017-06-20 | Apollo Endosurgery Us, Inc. | Intragastric implants with collapsible frames |
US9398969B2 (en) | 2010-10-19 | 2016-07-26 | Apollo Endosurgery, Inc. | Upper stomach gastric implants |
US9198790B2 (en) | 2010-10-19 | 2015-12-01 | Apollo Endosurgery, Inc. | Upper stomach gastric implants |
US10463520B2 (en) | 2011-01-21 | 2019-11-05 | Obalon Therapeutics, Inc. | Intragastric device |
KR101806089B1 (en) | 2011-01-21 | 2017-12-07 | 오발론 테라퓨틱스 인코퍼레이티드 | Intragastric Device |
US11779482B2 (en) | 2011-01-21 | 2023-10-10 | Reshape Lifesciences Inc. | Intragastric device |
US8740927B2 (en) * | 2011-01-21 | 2014-06-03 | Obalon Therapeutics Inc. | Intragastric device |
US20130289604A1 (en) * | 2011-01-21 | 2013-10-31 | Obalon Therapeutics, Inc | Intragastric device |
EP3284504A3 (en) * | 2011-01-21 | 2018-06-27 | Obalon Therapeutics, Inc. | Intragastric device |
US10610396B2 (en) | 2011-01-21 | 2020-04-07 | Obalon Therapeutics, Inc. | Intragastric device |
EP3117865A1 (en) * | 2011-01-21 | 2017-01-18 | Obalon Therapeutics, Inc. | Intragastric device |
US11737899B2 (en) | 2011-01-21 | 2023-08-29 | Reshape Lifesciences Inc. | Intragastric device |
US9827128B2 (en) | 2011-01-21 | 2017-11-28 | Obalon Therapeutics, Inc. | Intragastric device |
US11974934B2 (en) | 2011-01-21 | 2024-05-07 | Reshape Lifesciences Inc. | Intragastric device |
US9662239B2 (en) | 2011-01-21 | 2017-05-30 | Obalon Therapeutics, Inc. | Intragastric device |
US8888732B2 (en) | 2011-03-11 | 2014-11-18 | Apollo Endosurgery, Inc. | Intraluminal sleeve with active agents |
WO2012158972A3 (en) * | 2011-05-17 | 2013-01-31 | Endobese, Inc. | Method and apparatus for buoyant gastric implant |
WO2012158972A2 (en) * | 2011-05-17 | 2012-11-22 | Endobese, Inc. | Method and apparatus for buoyant gastric implant |
US20170042714A1 (en) * | 2011-05-17 | 2017-02-16 | Endobese, Inc. | Method and apparatus for buoyant gastric implant |
US10264995B2 (en) | 2013-12-04 | 2019-04-23 | Obalon Therapeutics, Inc. | Systems and methods for locating and/or characterizing intragastric devices |
US9895248B2 (en) | 2014-10-09 | 2018-02-20 | Obalon Therapeutics, Inc. | Ultrasonic systems and methods for locating and/or characterizing intragastric devices |
US20180346330A1 (en) * | 2015-11-24 | 2018-12-06 | Ge Aviation Systems Limited | Solid state delivery system |
US20210309514A1 (en) * | 2015-11-24 | 2021-10-07 | Ge Aviation Systems Limited | Solid state delivery system |
US11040875B2 (en) * | 2015-11-24 | 2021-06-22 | Ge Aviation Systems Limited | Solid state delivery system |
US10335303B2 (en) | 2015-12-07 | 2019-07-02 | Obalon Therapeutics, Inc. | Intragastric device |
US10537453B2 (en) | 2015-12-16 | 2020-01-21 | Obalon Therapeutics, Inc. | Intragastric device with expandable portions |
US10350100B2 (en) | 2016-04-12 | 2019-07-16 | Obalon Therapeutics, Inc. | System for detecting an intragastric balloon |
US11819433B2 (en) | 2016-11-04 | 2023-11-21 | Reshape Lifesciences Inc. | Pressure control system for intragastric device |
US20240050254A1 (en) * | 2019-09-20 | 2024-02-15 | Leonardo Salles De Almeida | Devices and method for bi-directional adjustment of intragastric balloons, and shut-off valve |
Also Published As
Publication number | Publication date |
---|---|
KR20100016353A (en) | 2010-02-12 |
WO2008127941A2 (en) | 2008-10-23 |
EP2139439A2 (en) | 2010-01-06 |
WO2008127941A3 (en) | 2008-12-11 |
BRPI0810639A2 (en) | 2017-06-06 |
ATE522191T1 (en) | 2011-09-15 |
CN101677868A (en) | 2010-03-24 |
CA2683715C (en) | 2015-11-24 |
JP2010523280A (en) | 2010-07-15 |
AU2008239896A1 (en) | 2008-10-23 |
US20100174307A1 (en) | 2010-07-08 |
EP2139439B1 (en) | 2011-08-31 |
US9173757B2 (en) | 2015-11-03 |
MX2009011021A (en) | 2009-10-29 |
CA2683715A1 (en) | 2008-10-23 |
HK1136482A1 (en) | 2010-07-02 |
ES2370929T3 (en) | 2011-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080255601A1 (en) | Apparatus and method for remote deflation of intragastric balloon | |
US8282666B2 (en) | Pressure sensing intragastric balloon | |
US12090075B2 (en) | Intragastric device | |
EP1814622B1 (en) | Intragastric volume-occupying device | |
US20120053612A1 (en) | Apparatus and method for intragastric balloon with in situ adjustment means | |
EP1978876B1 (en) | Devices for gastrointestinal stimulation | |
CN102917666B (en) | Gastric implanting device | |
US20060058829A1 (en) | Intragastric volume-occupying device | |
US20080243071A1 (en) | Intragastric balloon system and therapeutic processes and products |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ALLERGAN, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIRK, JANEL A.;REEL/FRAME:019159/0083 Effective date: 20070412 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |